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ABSTRACT OF DISSERTATION

NEUROBEHAVIORAL MEASUREMENTS OF NATURAL AND OPIOID REWARD
VALUE
In the last decade, (non)prescription opioid abuse, opioid use disorder (OUD)
diagnoses, and opioid-related overdoses have risen and represent a significant public
health concern. One method of understanding OUD is as a disorder of choice that
requires choosing opioid rewards at the expense of other nondrug rewards. The
characterization of OUD as a disorder of choice is important as it implicates decisionmaking processes as therapeutic targets, such as the valuation of opioid rewards.
However, reward-value measurement and interpretation are traditionally different in
substance abuse research compared to related fields such as economics, animal behavior,
and neuroeconomics and may be less effective for understanding how opioid rewards are
valued. The present research therefore used choice procedures in line with
behavioral/neuroeconomic studies to determine if drug-associated decision making could
be predicted from economic choice theories. In Experiment 1, rats completed an
isomorphic food-food probabilistic choice task with dynamic, unpredictable changes in
reward probability that required constant updating of reward values. After initial training,
the reward magnitude of one choice subsequently increased from one to two to three
pellets. Additionally, rats were split between the Signaled and Unsignaled groups to
understand how cues modulate reward value. After each choice, the Unsignaled group
received distinct choice-dependent cues that were uninformative of the choice outcome.
The Signaled group also received uninformative cues on one option, but the alternative
choice produced reward-predictive cues that informed the trial outcome as a win or loss.
Choice data were analyzed at a molar level using matching equations and molecular level
using reinforcement learning (RL) models to determine how probability, reward
magnitude, and reward-associated cues affected choice. Experiment 2 used an
allomorphic drug versus food procedure where the food reward for one option was
replaced by a self-administered remifentanil (REMI) infusion at doses of 1, 3 and 10
μg/kg. Finally, Experiment 3 assessed the potential for both REMI and food reward value
to be commonly scaled within the brain by examining changes in nucleus accumbens
(NAc) Oxygen (O2) dynamics. Results showed that increasing reward probability,
magnitude, and the presence of reward-associated cues all independently increased the
propensity of choosing the associated choice alternative, including REMI drug choices.
Additionally, both molar matching and molecular RL models successfully parameterized
rats’ decision dynamics. O2 dynamics were generally commensurate with the idea of a
common value signal for REMI and food with changes in O2 signaling scaling with the
reward magnitude of REMI rewards. Finally, RL model-derived reward prediction errors
significantly correlated with peak O2 activity for reward delivery, suggesting a possible

neurological mechanism of value updating. Results are discussed in terms of their
implications for current conceptualizations of substance use disorders including a
potential need to change the discourse surrounding how substance use disorders are
modeled experimentally. Overall, the present research provides evidence that a choice
model of substance use disorders may be a viable alternative to the disease model and
could facilitate future treatment options centered around economic principles.
KEYWORDS: Choice, Remifentanil, Matching, Reinforcement Learning, Reward
Prediction Error, Nucleus Accumbens
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CHAPTER 1:
VALUE AND ITS MEASUREMENT

Functional Consequences in Decision Sciences
A significant portion of the scientific literature is aimed at studying how to
attenuate maladaptive behavior. The behavior under study ranges from topics such as
getting people to exercise more, avoid unhealthy diets, stop using illicit substances,
prepare for long-term financial needs, and not spend money beyond their current means.
There is no doubt that many factors separate the propensity of one maladaptive behavior
from another. However, a common unifying mechanism is the choice to engage in one
action at the exclusion of others.
If choice is indeed a unifying mechanism of maladaptive behavior, then the
decision-making processes leading to choice are implicated as potential therapeutic
targets. For example, one of the most prominent paradigms in which decision making has
found predictive validity is delay discounting (Odum, 2011). Delay discounting describes
the decreased propensity for individuals to choose increasingly temporally distant
rewards in favor of more proximal ones. Interestingly, the impulsive choice propensity
characterized by delay discounting has shown remarkable clinical relevance through
associations with behavior such as illicit substance abuse (Mackillop et al., 2011),
substance abuse-related treatment outcomes (Loree, Lundahl, & Ledgerwood, 2015),
gambling (Alessi & Petry, 2003), the incurrence of debt (Beauchaine, Ben-David, & Sela,
2017), attention-deficit hyperactivity disorder (Patros et al., 2016), and obesity
(Rasmussen, Lawyer, & Reilly, 2010). However, perhaps more important was the
functional characterization of delayed rewards becoming less valuable through time.
Once known, interventions aimed at improving temporal perceptions (Smith, Marshall, &
Kirkpatrick, 2015), delay tolerance (Renda & Madden, 2016), working memory (Renda,
Stein, & Madden, 2015), and future orientation (Bulley & Gullo, 2017) became novel
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therapeutic strategies to reduce impulsive choice and, ostensibly, other maladaptive
choice behaviors.
Impulsive choice serves as a prominent example for how basic decision sciences
can reveal potential therapies for clinically relevant disorders. However, just as choice
can serve as a unifying process for many disorders, the hypothetical construct of reward
value can serve as a mediating mechanism across different forms of choice.
Reward valuation is a prominent point of study for the emerging sub disciplines
of behavioral economics and neuroeconomics seeking to understand clinically relevant
conditions under the umbrella term of reward pathology (e.g., Jarmolowicz, Reed,
DiGennaro Reed, & Bickel, 2016). Reward pathology generally refers to a
characterization of choices thought to be mediated by a disproportional valuation of one
choice alternative over others. For instance, in delay discounting, an impulsive chooser is
thought to overvalue rewards offered immediately or, inversely, undervalue future
rewards.

Brief History of the Concept of Value
Our current understanding about reward valuation stems from classical economic
thought traditionally ascribed to renaissance economist Blaise Pascal (Glimcher, 2011;
Glimcher, Camerer, Fehr, & Poldrack, 2013). Pascal was attempting to understand how
people should make decisions under uncertainty. For example, should an individual pay
45 florins for a ticket that provides a 50% chance at 100 florins? To answer decisions
involving uncertainty, Pascal proposed the idea of expected value (EV), or the expected
amount a decision returns on average. Shown in Equation 1, the EV is calculated by
multiplying the magnitude of a gain or loss (xi) by the probability of its occurrence (pi).
𝐸𝐸𝐸𝐸(𝑥𝑥) = � 𝑥𝑥𝑖𝑖 𝑝𝑝𝑖𝑖 (𝑥𝑥𝑖𝑖 )
𝑖𝑖

Thus, purchasing the ticket in the above example is a wise decision, as it produces an
expected value of 50 florins. Pascal’s contribution is notable as it is the first to ascribe
what decision makers should do, otherwise known as normative decision making.
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(1)

Although EV was an important step towards understanding decision making, it
became apparent to Daniel Bernoulli that it was an incomplete account (Bernoulli,
1738/1954; c.f. Glimcher, 2011). Bernoulli noted that not all individuals appeared to
behave as though absolute increases in reward amount translated to equivalent increases
in reward value. For instance, imagine a beggar comes upon a ticket that offers a 50%
chance of winning 20,000 florins. A wealthy individual notices the beggar’s ticket and
then offers the beggar a certain 7,000 florins for the ticket. According to normative theory
at the time, the beggar should refuse the ticket as it had an EV of 10,000 florins, or 3,000
more than the offer. However, if the beggar chooses to accept the certain 7,000 florins,
then it is not necessarily irrational, as it would mean both meal and shelter security for
some time to come.
To account for why the beggar might accept the offer, Bernoulli suggested the
idea of utility loosely described as subjective value. To get at the idea of the hidden
variable utility, Bernoulli computed the logarithm of an outcome’s amount to derive what
he referred to as utils. When Bernoulli’s calculations are applied, the adjusted EV value
of the beggar’s ticket becomes 2.15 utils (i.e., 0.5 * log [20,000]) which is less than the
wealthy man’s offer of 3.8 utils (i.e., 1.0 * log [7,000]). Thus, a decision to take the
certain 7,000 becomes justified. Stated differently, the utility of the beggar gaining a
certain 7,000 was greater than the possibility of getting 3,000 more florins (on average);
this is because rather than more florins producing a linear increase in reward value (as in
Pascal’s case), an increase in florins produces marginal gains reflective of a concave (or
negatively accelerating) utility function. The translation of Bernoulli’s subjective utility
today (Glimcher et al., 2013) has been generalized to forms similar to Equation 2
𝐸𝐸𝐸𝐸(𝑥𝑥) = � 𝑢𝑢𝑖𝑖 (𝑥𝑥𝑖𝑖 )𝑝𝑝𝑖𝑖 (𝑥𝑥𝑖𝑖 )
𝑖𝑖

(2)

in which the probability of a given outcome (pi(xi)) is multiplied by the outcome’s scaled
utility (ui(xi)) to produce expected utility (EU).
The notion of EU helped describe many violations of EV when the choices were
isomorphic, or between commodities of the same type (cf. Glimcher, 2011; Glimcher et

al., 2013). Once the appropriate utility function for a given set of choices was established,
it could be used to predict future choices. However, an inherent problem with the idea of
3

the utility function was in the scaling of how valuable one commodity was relative to a
different commodity, also known as allomorphic choice (Pareto, 1906/1971). Such
scaling is difficult is because EU is not observable and only revealed through observed
preferences. For instance, consider an example from Glimcher (2011) in which a
participant prefers apples to oranges to grapes and we assign each fruit utilities of 3, 2,
and 1, respectively. If our hypothetical person has two of each fruit, then they have a
combined utility of 12, but we want to raise it to 16. One simple solution would be to add
some combination of oranges and grapes to evenly raise the combined utility to 16.
However, what if further preference tests reveal a new ordering of apples > oranges >
pears > grapes > apricots. Suddenly, the assignment of utilities would necessarily change
to perhaps 5, 4, 3, 2, and, 1. Thus, the potential combination of fruits to raise our
participant’s overall utility to 16 is now altered.
The issue revealed by the above example is that measures of reward value do not
operate at the level of a cardinal scale. Stated differently, knowing that our participant
prefers oranges to grapes is an ordinal relationship, but it is unknown if oranges (2 utils)
truly offer twice the utility of grapes (1 util). By extension, knowing that oranges have a
utility of two from a model does not allow for the prediction of preferences against a yet
untested commodity. If a cardinal scale were existent, one could theoretically know
oranges have a “True” value of 2 utils that would be invariant and could be compared
against preferences for other commodities not assessed in the same context. The
limitations of utility are also further evidenced by more recent research showing that
preferences can be influenced by the dimension on which someone is asked to decide
(e.g., wins vs. losses) and the framing of information; these effects on decision making
and others are often referred to as the contextual dependency of decision-making (e.g.,
Birnbaum, 1992; Kahneman & Tversky, 1979). Thus, alluding back to the example of
delay discounting, simply knowing participants preferred temporally proximal rewards
over distant ones was not the primary outcome of the studies. Rather, it was the
understanding that rewards became less valuable as they were delayed through time (that
is, the functional consequence) that informed potential treatment strategies. In the same
way, future studies seeking to understand reward value will need to uncover the
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functional consequences that modulate reward value rather than solely compiling a list of
preferences amongst commodities.

The Value of Drugs of Abuse
A prominent area of research that often invokes the idea of reward value is in
substance abuse research. Illicit drug use is a pervasive public health concern estimated to
cost the US $193 billion annually (National Drug Intelligence Center Product, 2011).
Furthermore, the US is experiencing an opioid crisis stemming in part from the overprescription of opioid analgesics. In two decades, the number of annually dispensed
opioids nearly tripled to $248 million (Dart et al., 2015). Of those receiving opioids, 2129% misuse them, 8-12% develop opioid use disorder (OUD; Vowles et al., 2015), and 46% transition to illicit opioid use (Carlson, Nahhas, Martins, & Daniulaityte, 2016).
Additionally, 12.5 million people over the age of 12 reported past-year opioid misuse, 2.4
million people met OUD criteria (SAMHSA, 2017), and the mean opioid overdose deaths
nearly tripled since 2002 to an average of 91 per day across the US (CDC, 2017). Thus,
there is substantial public health cost of opioid use that highlights the need for treatment
and prevention strategies.
Substance use disorders (SUDs) like OUD have also been described as “disorders
of choice” (Kalivas, Volkow, & Seamans, 2005; Lamb, Maguire, Ginsburg, Pinkston, &
France, 2016), in that individuals must choose the drug reward at the expense of other
nondrug alternatives. Indeed, the notion of drug choices at the expense of nondrug
alternatives is also reflected in many DSM-V psychiatric criteria for OUD (Association,
2013). Thus, decision-making processes, including reward-value mechanisms, have the
potential to be therapeutic targets for reducing illicit drug use. Some laboratories have
embraced the choice mechanism of decision making (e.g., Ahmed, 2010; Banks &
Negus, 2012), but many use what is here referred to as single schedules of reinforcement
(e.g., Belin-Rauscent, Fouyssac, Bonci, & Belin, 2016; Jones & Comer, 2013; Marchant,
Li, & Shaham, 2013; N Kearns, A Gomez-Serrano, & J Tunstall, 2011; Sanchis‐Segura &
Spanagel, 2006), as described below
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Common Measures of Reward Value in Substance Abuse Research
Conditioned place preference (Spragg, 1940) is perhaps the most ubiquitously
used preclinical procedure (Childs & de Wit, 2009 in humans) to study the rewarding
efficacy of a drug without having individuals actually self-administer (Bardo & Bevins,
2000). In a typical 3-chamber procedure consisting of two side chambers adjoined by a
central chamber, an animal is initially placed in the central compartment and allowed
access to the two side chambers. The time that the animal spends in the two separate
rooms is measured as a baseline. Then, at separate time points, the animal is injected with
either a dose of drug or saline and restricted to either the drug- or saline-paired room,
which are made to be as distinct from one another as possible. Finally, after a number of
conditioning sessions for both drug and saline, the animal is again placed in the central
compartment and allowed free access to both rooms. The primary outcome measure is the
time spent in each room. If the time spent in the drug-paired chamber is increased (both
compared to the saline-paired chamber and baseline), then the results are interpreted as a
binary distinction of the drug having reward value.
While conditioned place preference can assess drug reward value through
noninvasive procedures, having an animal actually choose and take drug reward provides
greater face validity as it reflects what human drug users do. As such, self-administration
is generally referred to as the gold standard for assessing drug-associated reward value
(Weeks, 1962). In animals, self-administration occurs via implantation of a catheter into
the animal’s vein that allows for direct intravenous infusions of drug. Self-administration
procedures typically use a constant response requirement, otherwise known as a fixedratio (FR) schedule, on an operant such as a lever that, once completed, allows for selfadministration of a drug. The amount (or rate) of intake is then interpreted as an index of
how valuable or rewarding the drug is to a particular individual (Belin-Rauscent et al.,
2016).
Further methodologies have also been developed on top of self-administration to
striate individuals into more or less addiction-prone categories. One of the earliest was
the progressive ratio schedule (Griffiths, Findley, Brady, Dolan-Gutcher, & Robinson,
1975; Hodos, 1961), in which the response requirement for each subsequent self6

administered dose is increased either trial-by-trial or across sessions (Richardson &
Roberts, 1996). The primary measure with progressive ratio is the breakpoint, or the last
completed FR followed by a predetermined period of time during which no responding
occurs. Relatively higher breakpoints are interpreted as the individual exerting more
effort to earn the reward and, by extension, evidence of the reward providing more utility.
Another variant is the escalation model (Ahmed, Walker, & Koob, 2000), where rats are
given either short (~1-3 hr) or long (~ 6 hr) access to self-administer a drug. Rats given
extended 6-hr access will typically increase their rate of intake beyond the short access
group and show resistance to drug extinction or continued use despite concomitant
punishment (e.g., shock; Ahmed & Koob, 1998; Edwards & Koob, 2013). The escalation
of drug intake and resistance to punishment ostensibly represents a divergence from
reward-based decision making to compulsive decisions for drug reward, regardless of
consequences.
A final paradigm is an adaptation of the economic demand model (Hursh &
Silberberg, 2008). In demand procedures, the value of a commodity is assessed by
determining an individual’s response rate for a given commodity across different levels
of an assumed unitary scale, unit price. Unit price is defined as the cost-benefit ratio of
the reward magnitude divided by its cost (e.g., response requirement) that is manipulated
across different experimental components. A demand equation, such as the exponential
form shown in Equation 3, is then fit to the data.
𝑄𝑄 = 𝑄𝑄0 + 𝑘𝑘(𝑒𝑒 −𝛼𝛼𝛼𝛼 − 1)

In Equation 3, Q0 is the value of a commodity when it is freely available (or at least at

(3)

minimum price), α determines the rate of decline in response rates as a function of unit
price (or a commodity’s elasticity), and k is a scalar constant. While similar to
progressive ratios, demand equations fit rates of intake as a function of unit price rather
than only looking at the FR where responding stops. Commodities with relatively higher
α parameters are said to be more elastic and maintain less reward value as a function of
increases in price. Therefore, a commodity of greater reward value may have a relatively
higher Q0 and/or lower α. The demand equation can suitably parametrize several different
drug commodities (Bentzley, Fender, & Aston-Jones, 2013; Hursh & Silberberg, 2008),
and there is some evidence that testing two commodities in isolation can predict ordinal
7

preferences in choice (Johnson & Bickel, 2006; Kearns, Kim, Tunstall, & Silberberg,
2017; Schwartz, Kim, Silberberg, & Kearns, 2017; but see Schwartz, Silberberg, Casey,
Paukner, & Suomi, 2016).

Theoretical and Pragmatic Issues with Single Schedule Measures
Rate Measures are Dissociable from Preferences
While there are merits to the above approaches, each procedure, when used to
quantify the reward value of a single commodity (i.e., a single schedule), suffers from
similar pragmatic and theoretical issues. One issue is the assumption that response rates
serve as a valid measure for the utility of a commodity (Banks & Negus, 2012).
Economic determination of reward value uses choice as the gold standard, and rates are
often dissociated from choice preferences (e.g., Bonem & Crossman, 1988; Picker &
Poling, 1982). Perhaps the most recognizable dissociation between rates and preference
comes from the self-administration dose-response curve. In single schedules, increasing
doses often produces a bitonic, “inverted U-shape” in response rates (e.g., Katz, 1989;
Mello & Negus, 1996; Weeks, 1962), where intermediate dose values produce the highest
rates of responding. Thus, one would conclude that the intermediate doses are the most
rewarding due to the elevated rates of responding. The logic for higher doses decreasing
rates is often attributed to aversive and nonspecific effects (Katz, 1989). However, when
individuals are offered a choice between dose values and some other commodity (e.g.,
food) or a higher dose of the drug, the higher dose often produces larger drug preferences
(Beckmann, Chow, & Hutsell, 2019; Freeman & Woolverton, 2011; Hutto & Crowder,
1997; Johanson & Schuster, 1975; Negus, 2006). Additionally, individuals described as
‘compulsive’ drug users that show escalated drug use in single schedules often do not
show corroborative drug preference changes in choice procedures (Caprioli, Zeric,
Thorndike, & Venniro, 2015; Lenoir, Serre, Cantin, & Ahmed, 2007; Schwartz et al.,
2017; c.f. Lenoir, Cantin, Vanhille, Serre, & Ahmed, 2013; Negus & Rice, 2009 ). Such
dissociation suggests that rate measures of reward efficacy are not in agreement with
choice procedures and are susceptible to other factors independent of the value of the
commodity here called direct effects (Katz, 1989).
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Direct Effects
Two notable direct effects apparent from single schedules are satiation and
motoric effects. Satiation refers to the hypothesis that the decrease in rates of responding
at relatively higher doses is due to an individual needing fewer infusions to reach
threshold levels of reward. Evidence for satiation comes from findings that animals will
titrate their intake and show stable inter-reward-intervals as a function of dose (Katz,
1989), and that higher doses can lead to increased latencies to respond in choice
procedures without concomitant decreases in drug preference (Beckmann et al., 2019).
Additionally, forced time-out periods between doses of self-administered cocaine can
change the peak of the dose-response curve. Short timeouts shift the peak of the function
to lower doses (Caine & Koob, 1994), while longer timeouts do not show the decreased
rates or inverted U-shaped curve typical at higher doses (Griffiths, Bradford, & Brady,
1979). Finally, relatively large amounts of food (Goldberg, 1973) and intracranial selfstimulation voltage (Reynolds, 1958) can also produce decreases in response rates similar
to a dose-response curve. Thus, some of the apparent decreases in response rates may be
due to a satiety effect of the individual spacing their reward intake that, in temporally
constrained procedures such as single schedules, appears as a reduction in value.
The issue of motoric effects has two components: the rate-altering effects of some
drugs and rate-dependent effects. In terms of gross motoric effects, stimulants (Antoniou,
Kafetzopoulos, Papadopoulou-Daifoti, Hyphantis, & Marselos, 1998; Witkin, 1993) and
opioids (Browne & Segal, 1980; Smith, Greene-Naples, Lyle, Iordanou, & Felder, 2009)
can increase or decrease locomotor activity that is both temporally dependent and can
change between acute versus chronic administration. Thus, when an individual’s ability
to move is directly related to the measure of value, compounds that can affect motoric
ability confound motoric and valuation processes. The potentially confounding motor
effects are also a primary concern whenever a treatment is applied (be it pharmacological,
genetic, or anatomical), as it can be difficult to dissociate any observed rate changes as
being due to altered reinforcing efficacy of the scheduled commodity from a motoricaltering effect of the treatment (Mello & Negus, 1996).
The difficulty of dissociating motoric from preference effects is also further
compounded by rate dependency (Branch, 1984). Rate dependency describes an
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interaction of rate-altering effects with an individual’s baseline performance. Rate
increases are more probable at lower baseline rates while decreases more probable with
higher baselines. To demonstrate rate dependency, researchers have manipulated the
baseline rate of responding through using either interval or ratio schedules (Kelleher &
Morse, 1964; Lucki, 1983; McMillan, 1969; Thompson, Honor, Verchota, & Cleary,
1984) that tend to produce lower and higher rates of responding, respectively (Powell,
Honey, & Symbaluk, 2016). For example, individuals experienced with both schedules
that are challenged by the same doses of amphetamine show divergent increases and
decreases in rates depending on whether the baseline rate of performance was lower or
higher, respectively (e.g., Kelleher & Morse, 1964). Importantly, the effects of rate
dependency are contingent upon the baseline rate of behavior and not necessarily the type
of schedule used (McMillan, 1969). Thus, the issue of motoric effects confounding single
schedule measures of value is robust and makes comparisons of both within- and
between-subject manipulations difficult to interpret.
Inherent Invocation of the Cardinal Scale
A final more theoretical issue with single schedules is the lack of recognizing the
contextual dependency of a commodity’s value by offering it in isolation. The contextualdependency of decisions has long been recognized in economics (e.g., Glimcher, 2011;
Kahneman & Tversky, 1979) and represents an important theoretical assumption: choice
preferences are relative to other available commodities. That single schedules offer
reward commodities in isolation implies an assumption that the obtained measure of
reward value is indicative of an inherent or “True” value, similar to the idea of the
cardinal scale. However, from the earlier example of assigning utility values to different
fruits, it is known that the idea of a cardinal scale is flawed.
One prominent invocation of cardinal scale ideology (despite recognizing the
variability of reward value) is the use of the essential value metric stemming from
economic demand. Essential value (Hursh & Silberberg, 2008) describes the elasticity of
a commodity (α) across the assumed unidimensional space of unit price after normalizing
for differences in maximum consumption (Q0; Equation 3). The goal of the essential
value metric is to create a single measure of reward value that can compare commodities
across similar procedures (e.g., Christensen, Silberberg, Hursh, Huntsberry, & Riley,
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2008; Schwartz et al., 2019; Smethells, Harris, Burroughs, Hursh, & LeSage, 2018) and
be used to identify ‘addiction-like’ vulnerabilities in decision-making (e.g., Bentzley,
Jhou, & Aston-Jones, 2014; Murphy, MacKillop, Skidmore, & Pederson, 2009).
There are multiple problems with the idea that reward value as a function of unit
price (i.e., essential value) is representative of an absolute measurement of value. First, as
already mentioned, essential value invokes the idea of an invariant value measure that can
be placed upon a cardinal scale from which to compare all commodities against. Second,
the dimension of unit price fails to take into account that different dimensions (e.g.,
effort, time, magnitude, probability, etc.) are not psychophysically scaled the same
(Stevens, 1957). For example, unit price is defined as the magnitude of a reward divided
by its cost (except cost is ubiquitously effort). If unit price indeed represents a
unidimensional space, then manipulating either the cost or magnitude of a commodity,
such that unit prices are equivalent, should result in equivalent measurements of
elasticity. However, manipulating cost or magnitude produces differences in essential
value estimates (Smith, Rupprecht, Sved, & Donny, 2016) and subjects’ choices between
commodities of identical unit prices (but varying in cost or magnitude) are not indifferent
(Madden, Bickel, & Jacobs, 2000). Essential value is also altered by the presence of a
concurrently available commodity (Carroll & Rodefer, 1993; Smethells et al., 2018) and
the overall length of time that a commodity is available (Carroll & Rodefer, 1993; Foster,
Kinloch, & Poling, 2011). Thus, unit price is not a singular dimension for comparing
reward value, and the metric of essential value is dependent upon the decision-making
context.
While the above inconsistencies are troubling for essential value, they are also
predictable from a differentially scaled multidimensional view of reward value.
Differential scaling suggests that a change in one dimension (e.g., effort) may have
different psychophysical effects than the addition of one food reward (i.e., magnitude),
despite the same unit price. Therefore, inconsistencies in manipulations of magnitude or
effort that return different essential value measurements are not without theoretical cause.
Furthermore, manipulations of different commodity-relevant dimensions can have
independent effects on choice preferences (Arvanitogiannis & Shizgal, 2008; Beckmann
et al., 2019; Smith, Beckmann, & Zentall, 2017a), which are not possible under the unit
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price unidimensional assumption. Indeed, the inconsistencies in effects with the demand
paradigm point to the necessity of a multidimensional view (described in detail below).
A distinction should be made between demand as a subdomain of economics and
the essential value metric. The above section denotes issues with the use of essential
value as a unifying metric for reward value; these same issues do not necessarily extend
to broader applications of demand. Indeed, demand can serve as a useful behavioral
economic tool (Bickel, Marsch, & Carroll, 2000) grounded by economic principles
(Rachlin, Battalio, Kagel, & Green, 1981; Rachlin, Green, Kagel, & Battalio, 1976).
Furthermore, demand can aid in understanding choice mechanisms such as cross-price
elasticity assessments of substitutes and complements (Rachlin et al., 1976). However,
researchers using essential value or single schedules as metrics of reward value should
appreciate the shortcomings of single schedule measures, the contextual dependency of
reward value, and the multidimensional nature of reward value less they become
overconfident in their measures’ predictive efficacy.

Multidimensional Scaling of Reward Value: The Progression of Matching
One reason why single--schedule paradigms might persist despite the noted issues
is hysteresis. Rates of behavior were originally thought to be a measure of reward
strength (e.g., Skinner, 1932; Skinner, 1938), and some have posited that differences
between rate and choice measures might be reflective of multiple decision systems or
independent aspects of reward value (e.g., Berridge, Robinson, & Aldridge, 2009; Regier
& Redish, 2015). A discussion of the latter point would extend beyond the scope of this
manuscript. Rather, this section is meant to describe an alternative approach from the
experimental analysis of behavior (EAB) literature that was also steeped in the notion of
response rates as reward strength. However, upon meeting theoretical challenges similar
to those noted above, the EAB field altered their formulations of reward value as told
through the progression of the matching equations.
Tautological Matching
Matching was originally derived from the observation that response rates came
under orderly control of relative schedules of reinforcement (Davison & McCarthy,
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1988). In a typical matching experiment, subjects can choose to allocate responses to two
operants that reward responding at different (and locally variable) rates, also known as
variable interval (VI) schedules. Under concurrent VI schedules, Herrnstein (Herrnstein,
1961) originally noted that the relative response rates of pigeons allocated their
responding according to the relative reinforcement obtained on each key. Herrnstein
quantified the effect using Equation 4
𝐵𝐵1
𝑅𝑅1
=
𝐵𝐵2
𝑅𝑅2

(4)

where B refers to the absolute behavior (response rates) between choice alternatives and

R refers to the obtained reinforcers for choice 1 and 2. Although originally formulated for
relative rates of responding and reinforcers, both sides of the matching equation were
easily expanded to other dimensions. For example, subsequent work showed that relative
responding matched dimensions such as relative delay and magnitude of reward while
relative rates could be substituted for relative time allocation (Davison & McCarthy,
1988).
While Equation 4 does well to describe behavior under a variety of conditions, it
soon needed alterations stemming from pragmatic issues in the use of rates as the output
measure and in the extension to single schedules or operants (c.f., Davison & McCarthy,
1988; Herrnstein, 1970, 1974). Herrnstein originally thought that response rates were a
linear function of reward rates. However, Catania (1963a, 1963b) showed non-linearity
between response and reinforcer rates due in part to an organism having a maximum
motoric output. Thus, any subsequent formulations typically took on a hyperbolic form to
allow for an asymptote in responding. A second extension was also needed to account for
the fact that responding on scheduled operants was not the only behavior available to an
individual. Indeed, typically non-measured ‘leisure behavior’ was recognized in matching
research and encompassed a class of any behavior other than responding for the
scheduled commodity (Be). Rather than simply being left out of the equations as error,
leisure behavior was thought of as choice behavior (Herrnstein, 1970). The non-linear
functionality between rates and reinforcers as well as leisure behavior were encompassed
in Equation 5.
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𝐵𝐵1
𝑘𝑘𝑅𝑅1
=
𝐵𝐵𝑒𝑒 … + 𝐵𝐵𝑁𝑁 𝑅𝑅𝑒𝑒 … + 𝑅𝑅𝑁𝑁

(5)

Colloquially known as Herrnstein’s hyperbola, Equation 5 suggests the rate of responding
for a behavior (B1, B2... BN) is now a function of its rate of reinforcement scaled
according to an organism’s maximal rate of responding for a given operant (k) divided by
the rate of reinforcement for all other extraneous reinforcement (Re) and other
concurrently available choices (RN). Note that while the use of response rate as a
dependent variable here suffers from similar issues noted above, scaling behavior
according to an individual’s own motoric output takes one step towards trying to rectify
the influence of extraneous variables other than experimenter manipulated variables (e.g.,
reward rate).
Generalized Matching
Although Herrnstein’s hyperbola was a respectable step in attempting to control
for confounding issues in rate measures of behavior, it was not consistent with empirical
findings (Davison & McCarthy, 1988; McDowell, 2005, 2013). Namely, estimates of k
and Re were not always independent or invariant. Herrnstein’s hyperbola was therefore
replaced by the somewhat less theoretical generalized matching law (Baum, 1974) shown
in Equation 6.
𝐵𝐵1
𝑅𝑅1 𝑠𝑠
= 𝑏𝑏 � �
𝐵𝐵2
𝑅𝑅2

(6)

Equation 6 was the beginning of a more modern class of matching equations called power
functions (McDowell, 2005) that suggest that behavior (B) is a function of reinforcement
rate (R) scaled with a power term (s) and multiplied by a bias term (b). The use of bias
and sensitivity account for deviations from matching similar to Herrnstein’s attempts, but
in somewhat less of a theoretical manner using modeled free parameters. However, the
sensitivity term (s) can be interpreted similar to power functions from previouslymentioned psychophysical studies (e.g., Stevens, 1957) as an individual’s sensitivity to
differences between and changes in relative rates of reinforcement. However, the
behavior of interest needs to be measured under multiple levels of reinforcement rates to
obtain theoretically accurate estimates of s. For tautological matching to occur, estimates
of s and b should approximate values of one indicating that the relative response behavior
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closely followed changes in relative reward rates and was without bias for either choice
alternative. Despite some limitations of interpretation, the generalized matching equation
has shown efficacy in describing a range of (non)human data from primarily concurrent
VI choice studies (e.g., Baum & Rachlin, 1969; Wearden & Burgess, 1982) and can be an
effective tool to describe how sensitive individuals’ preferences are to changes in
experimenter-manipulated variables.
The progression of matching was still not finished. As noted earlier, multiple
dimensions can affect behavior (Baum & Rachlin, 1969; Rachlin, 1971). To account for
multiple dimensions affecting behavior, concatenation of each was suggested as shown in
Equation 7.
𝐵𝐵1
𝑅𝑅1 𝑀𝑀1 𝐼𝐼1 … 𝑋𝑋1
= 𝑏𝑏 ∗
∗
∗ ∗
𝐵𝐵2
𝑅𝑅2 𝑀𝑀2 𝐼𝐼2 … 𝑋𝑋2

(7)

In Equation 7, relative behavior is a function of the relative rates (R), magnitude (M), and
immediacy (the inverse of delay; I) of reinforcement, while X denotes any number of not
listed dimensions (X) between two alternatives (1 and 2). Going one step further, raising
each dimension to a sensitivity term grants Equation 8:
𝑅𝑅1 𝑆𝑆𝑅𝑅
𝑀𝑀1 𝑆𝑆𝑀𝑀 𝐼𝐼1 𝑆𝑆𝐼𝐼 … 𝑋𝑋1 𝑆𝑆𝑋𝑋
𝐵𝐵1
= 𝑏𝑏 ∗ � � ∗ � � ∗ � � ∗ �
�
𝐵𝐵2
𝑅𝑅2
𝑀𝑀2
𝐼𝐼2
… 𝑋𝑋2

(8)

where SR,M,I...X represent scaled sensitives to changes in each of the relevant dimensions.
Thus, matching is primarily a formalized restatement of empirical findings known to
affect behavior (i.e., differential scaling of multiple dimensions). When coupled with

modern statistical approaches (Young, 2017), Equation 8 is an effective tool at capturing
individual differences and couches them in a theoretically parsimonious interpretation of
differences in contact with relevant reward dimensions. Furthermore, although each
dimension is said to be independent of others, the use of mathematical formulation would
allow for empirical testing of such assumptions (Davison & McCarthy, 1988). Finally,
for the sake of completeness, we formulate what has been an overriding assumption in
Equation 9
𝐵𝐵1 𝑉𝑉1
=
𝐵𝐵2 𝑉𝑉2

(9)

where the relative rates of behavior (B1 and B2) are reflective of a relative value (V1 and
V2) for available alternatives.
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The progression of the matching equations exemplifies an approach to the
treatment of data through quantitative models. Equation 5 is of particular importance, as
Re was meant to correct for some of the motoric problems previously noted with singleschedule measures of reward value. However, through formalizing testable predictions, it
was shown that Re could not fully reconcile confounding motoric effects. Such instances
show how mathematical models can be “better than mere words” (Mazur, 2006, p. 276)
because they require unambiguous specification of theoretical assumptions. Ultimately,
single schedule measures would become less prevalent in the matching literature (but see
Killeen, 1994), perhaps with the suggestion that they are less robust or representative
measures of reward value. The prevalence of single schedules in substance abuse is also
not necessarily due to failures of matching in drug-associated decisions, as they can
describe drug and nondrug choices (Beckmann et al., 2019). Thus, the distinction of
measurement is important for the quantification of value both in understanding factors
that lead to drug choices and for the relatively new neuroeconomic field that seeks to find
neural underpinnings of reward value in the brain (Glimcher et al., 2013).

Reward Value at Another Level: Neuroeconomic Reductionism
To this point, the discussion of reward value has revolved around the assumption
of Equation 9: that measured behavior is a reflection of the hypothetical construct of
value, or utility in the subjective case. Even in the matching equations, behavior is
described as if a scaled multidimensional utility function is utilized to compare
alternatives. The use of the phrase ‘as if’ is important (Glimcher, 2011; Glimcher, Dorris,
& Bayer, 2005), as it serves to distance oneself from the false notion that individuals are
consciously computing such values when they make decisions. However, if individuals
do not consciously represent and adhere to their own utility functions, how are decisions
made? The suggestion by the field of neuroeconomics is that decisions are made by the
physiological architecture of neurons in the brain.
Glimcher (2011) suggested that one goal of neuroeconomics will be to move from
the statement of individuals acting as if they represent values on a utility function to
individuals making decisions because of value computations in the brain. However, for
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brain value computations to be verified, understanding the implicated philosophical
assumptions and a valid means of testing hypotheses are necessary. A core philosophical
assumption for neuroeconomics is the idea of reductionism (McCauley, 2007), or that
phenomena observed at one level of analysis can be reduced to another. For example, one
mechanism as to why (non)humans may behave according to a monotonic utility function
for food intake is because it leads to reproductive success. Thus, the concept of fitness
maximization in evolutionary theory is a proposed mechanism for reducing the concept
of rational human agency onto similar rational agency seen in animals (Kacelnik, 2006;
Stephens, 2008). A further reduction could then imply that neuronal architectures lead to
fitness maximization in animals that could be similarly present in mediating human
decision making.
The second requirement for a neuroeconomic framework is a valid form of
hypothesis testing. In order to test reductions in higher-order decision theories at the level
of physiology, Glimcher (2011) suggested that researchers start by making assumptions
from what is already known (i.e., utility models). Although no single utility function can
describe choice data without fail, beginning with utility models allows for the
identification of neural circuits involved in valuation when behavior is utility-theory
compliant. Therefore, to test if brain areas “encode” reward value, physiological
recordings of neuron activity or neurotransmitters are typically correlated with behavioral
measures of reward value.
Mesocorticolimbic Encoding of Ostensible Reward Prediction Errors
One promising line of neuroeconomics research was the identification of an
ostensible reward prediction error (RPE). Schultz and colleagues (Schultz, Apicella, &
Ljungberg, 1993) measured ventral striatum neuron activation as thirsty monkeys learned
a cued choice procedure in which a discriminative stimulus signaled operant-contingent
availability of a delayed juice reward (see also Apicella, Ljungberg, Scarnati, & Schultz,
1991; Schultz, Apicella, Scarnati, & Ljungberg, 1992). Early in training, striatal neurons
displayed a burst firing pattern of activation following reward delivery and a brief
cessation of firing following reward omission. However, the pattern of neuronal activity
also changed as the monkeys learned the task. Eventually the striatal neurons stopped
firing when the reward was delivered and activated instead with the onset of the cue
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signaling reward availability. The activity of the neurons therefore suggested not merely
encoding a sensitivity to reward delivery, but also of cues providing information about
reward and violations of reward expectations.
To further assess the plausibility of the RPE hypothesis, subsequent studies
looked at neuronal activation under more uncertain conditions. For instance, providing
reward in a random, behaviorally non-contingent manner can reestablish burst firing of
striatal neurons to reward delivery (Mirenowicz & Schultz, 1994). Additionally, burst
firing appears to scale with probability of reward. Fiorillo, Tobler, and Schultz (2003)
trained monkeys on a Pavlovian procedure where a cue was probabilistically followed by
a delayed reward. The results showed that burst firing to reward delivery was inversely
related to the scheduled probability of that reward. However, burst firing to the cue
predicting reward delivery was positively related to the scheduled probability, and
activity between the cue and reward showed an inverted U-shaped pattern with maximal
activity at 50% reward probability. Together, the results suggested that striatal neuron
firing was encoding information about reward wherein reward-associated firing seemed
contingent on how surprising an event was, while cue-associated activation was
contingent on reward-predictive associability.
The finding of neural RPEs was exciting for multiple reasons, one being the
possibility of an ostensibly common physiological signal for reward value (i.e., a
common currency).The validation of a common currency mechanism would suggest that
individuals do make decisions according to and because of neural representations of a
utility function and provides a biological target to treat disorders stemming from reward
pathologies (such as substance use disorders). Subsequent work has therefore attempted
to evaluate the validity of the RPE as a common currency mechanism by testing
commodities across a range of dimensions. For example, preclinical research has shown
that RPEs in mesocorticolimbic areas appear to scale with changes in probability (Fiorillo
et al., 2003; Hart, Rutledge, Glimcher, & Phillips, 2014; Lak, Stauffer, & Schultz, 2014),
magnitude (Hart, Haney, Foltin, & Fischman, 2000; Kobayashi & Schultz, 2008; PadoaSchioppa & Assad, 2006; Saddoris, Cacciapaglia, Wightman, & Carelli, 2015a) and delay
(Day, Jones, Wightman, & Carelli, 2010; Kobayashi & Schultz, 2008; Roesch, Calu, &
Schoenbaum, 2007; Saddoris et al., 2015b) for either rewards or reward-associated cues.
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Additionally, with modest success, some studies have manipulated mesocorticolimbic
activity to causally relate RPEs to preferences (Hamid et al., 2016; Saddoris et al., 2015b;
Stopper, Maric, Montes, Wiedman, & Floresco, 2014).
Ostensible RPE signals have also been found in human mesocorticolimbicassociated nuclei using functional magnetic resonance imaging techniques (fMRI; Levy
& Glimcher, 2012). fMRI measures blood oxygen level-dependent (BOLD) signals that
act as a proxy for brain region activity (discussed more below in the Oxygen
Measurement and its Relation to Neuron Activity section) and allow for recording of
brain activity similar to electrodes used in preclinical studies. However, assessment of
what reward-relevant dimensions human RPEs are sensitive to is somewhat precluded
due to prevalent use of model-based fMRI (O'Doherty, Hampton, & Kim, 2007). In
model-based fMRI, reward-relevant dimensions are often converted to a prediction
derived from a utility function (such as an expected value) that is correlated with brain
activity. As such, the scaling of area-specific activity with a singular dimension is less
available. Still, several studies using magnitude, probability, and delay manipulations on
choice alternatives have shown mesocorticolimbic activity is related to model-derived
parameters (Abler, Walter, Erk, Kammerer, & Spitzer, 2006; Ballard & Knutson, 2009;
Gläscher, Daw, Dayan, & O'Doherty, 2010; Kable & Glimcher, 2007; Knutson, Taylor,
Kaufman, Peterson, & Glover, 2005), and suggests RPE scaling of reward-relevant
dimensions. Additionally, two recent meta-analyses of fMRI studies assessing
correlations between brain activity and decision-making have found homology of results
to two mesocorticolimbic areas: the striatum (both ventral and dorsal) and prefrontal
cortices (Garrison, Erdeniz, & Done, 2013; Levy & Glimcher, 2012). Thus, in order for
greater homology between (pre)clinical literatures and more informed hypothesis testing,
animal research should also increase its use of models describing preference behavior
with neurological measures of reward value.
Molecular Analysis of Neurobehavioral Decision Making
One class of models that lends itself to the reductionist approach of
neuroeconomics is reinforcement learning (RL) models (Sutton & Barto, 1998). RL
models stem from Pavlovian conditioning research (Bush & Mosteller, 1953; Rescorla &
Wagner, 1972) and suggest learning is dependent upon the unpredictability of rewards
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and cues. The original intent of the Pavlovian equations was to model conditioned
responses (CR) that occur when pairing a to-be conditioned stimulus (CS) with a
biologically-relevant unconditioned stimulus (US; Rescorla & Wagner, 1972). The
models later conceptually changed to modeling the associative strength between stimulus
and reward in the modernized Equation 10
𝑉𝑉𝐴𝐴𝑡𝑡+1 = 𝑉𝑉𝐴𝐴𝑡𝑡 + 𝛼𝛼(𝜆𝜆 − 𝑉𝑉𝐴𝐴𝑡𝑡 )

(10)

where the associative strength (V) of stimulus A on the next trial (t) is a function of the
difference between the current strength and asymptote of conditioning (λ) scaled by a

learning rate parameter (α). Thus, similar to the idea of RPEs, the change in associative
strength is a scaled correction between previous and new learning. Although inaccurate
under certain conditions (e.g., Miller, Barnet, & Grahame, 1995), Equation 10 has served
as a highly influential description of several conditioning phenomena (Miller et al., 1995;
Rescorla, 2003).
Given the findings of Schultz and colleagues (e.g., Schultz et al., 1993), the use of
RL models makes intuitive sense as it already applies a prediction correction algorithm as
a learning mechanism. Additionally, application of RL models from computer science
formulations (Sutton & Barto, 1998) and behavioral conditioning describe the neural RPE
data well (Schultz, Dayan, & Montague, 1997). One formalization of how an RL model
can update reward values is shown in Equation 11:
𝑉𝑉𝐴𝐴𝑡𝑡+1 = 𝑉𝑉𝐴𝐴𝑡𝑡 + 𝛿𝛿𝑡𝑡

(11)

𝛿𝛿𝐴𝐴𝑡𝑡 = 𝛼𝛼(𝜆𝜆𝐴𝐴𝑡𝑡 − 𝑉𝑉𝐴𝐴𝑡𝑡 )

(12)

where the value of commodity A on the next trial (t) is defined by the summation of its

current value and the reward prediction error (δt). The reward prediction error is defined
in Equation 12.
In Equation 12, the difference between a commodity’s expected value (V) and the
received reward (λ) is scaled by a learning parameter (α). Equation 12 is applied
independently to a commodity when it is chosen to determine the expected value for each
reward. Then, to determine action selection, the values of the commodities are compared
according to a softmax decision rule (Sutton & Barto, 1998) to determine the probability
of a choice:
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𝑝𝑝𝑝𝑝ℎ𝐴𝐴𝑡𝑡 =

1
1 + 𝑒𝑒𝑒𝑒𝑒𝑒(−[𝛽𝛽(𝑉𝑉𝐴𝐴𝑡𝑡 − 𝑉𝑉𝐵𝐵𝑡𝑡 )])

In Equation 13, the probability of choosing commodity A on the current trial (t) is

(13)

determined by the difference between reward values (V) for commodity A and B scaled
by an inverse temperature parameter (β). Hierarchical RL models such as in Equations
11-13 have been shown to capture choice data of both humans (Rutledge et al., 2009) and
animals (Groman, Rich, Smith, Lee, & Taylor, 2017). Additionally, RL models have the
added benefit of being molecular analyses that capture choice-by-choice dynamics. While
descriptive molar models such as the matching equation are often sufficient for
describing choice behavior, their interpretation as a causal definition of choice behavior
is strained due to its averaging over conditions of choice. Alternatively, RL models make
a prediction for every choice that, if sufficient, grants one step closer to a causal
interpretation.

The Value in Studying Value: Applications to Opioid Use Disorder
The previous sections illustrated how the determination of reward value is more
complex than perhaps let on by single schedule measures prevalent in substance abuse
research. In order to properly assess the conditions under which a commodity is favorably
chosen, experiments need to explore a range of conditions across multiple dimensions of
reinforcement relative to other commodities. The necessity for complex, relative models
of reward also serves for a better representation of how drug users make drug-associated
decisions in their natural environments. Substance users are not isolated to a box where
the only available alternatives are to take drug or leisure activities (i.e., Be). Thus,
providing another biologically relevant commodity (e.g., food, money) is necessary for a
better theoretical understanding of reward value and to improve the face validity of the
model as a representative measure of what occurs in a natural environment (i.e., beyond
the laboratory).
The discussion of valuation as it relates to substance use disorders is also
predicated on one important point: that substance use disorders can be characterized as
disorders of choice. Indeed, there is growing consensuses that choice mechanisms affect
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illicit substance use. For example, the propensity to choose drug rewards can be altered
by the available dose, cost to obtain drug reward, and the presence of an alternative
reinforcer (Banks & Negus, 2012; Bickel, Johnson, Koffarnus, MacKillop, & Murphy,
2014; Davis et al., 2016; Lamb et al., 2016; Moeller & Stoops, 2015). Such results
therefore suggest that drug-associated decision making is similarly economic as non-drug
choices.
A competing hypothesis with drug taking as a disorder of choice is that of
compulsion (Kalivas et al., 2005; Lubman, Yücel, & Pantelis, 2004; Vandaele & Janak,
2018). For a compulsive drug user, drug use is poorly mediated (if at all) by value-based
decision making. Ideas of compulsive drug use are typically predicated on the idea that
continued drug use leads to brain changes (e.g., Everitt & Robbins, 2016; Volkow, Koob,
& McLellan, 2016; Volkow, Wang, Fowler, & Tomasi, 2012) that lead to an insensitivity
to behavioral consequences. However, multiple theoretical and empirical problems exist
with the idea of compulsion, not the least of which is that the definition of compulsion
changes over time (Heyman, 2003, 2013a; Hogarth, 2018). For example, the brain
changes that compulsive use is predicated on involve post-hoc correlational evidence that
lacks causal inference. Additionally, incidents of drug experimentation leading to regular
use is low, contingency management programs offering incentives contingent on drugabstinence are highly effective at curbing long time use, and users often remit without
treatment (Davis et al., 2016; Heyman, 2003, 2013b). Even rats given extended access to
self-administer drugs of abuse often do not show potentiated drug preferences after they
become labeled “compulsive users” (Caprioli et al., 2015; Lenoir et al., 2007; Schwartz et
al., 2017). Thus, the suggestion is not that brain changes do not occur, but that the
changes may not necessarily preclude an individual from making value-based economic
decisions (Heyman, 2013b).
Although drug-associated brain changes may not be a useful determinant for
describing drug preferences, they may serve as a useful testing ground for neuroeconomic
hypotheses. At present, the idea of a cardinal utility scale in the brain is predicated on
mesocorticolimbic activity scaling with different metrics of behaviorally derived reward
value. However, drugs of abuse also directly alter mesocorticolimbic activity through
their pharmacodynamics (Iversen, Iversen, Bloom, & Roth, 2008; Pierce & Kumaresan,
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2006) and produce activity that may not necessarily be related to value. For instance,
sensitization or tolerance to the pharmacodynamics of opioid μ receptor agonists (Fields
& Margolis, 2015; Grecksch et al., 2006; Williams, Christie, & Manzoni, 2001) may
produce signals within mesocorticolimbic areas that do not scale with behavioral reward
value measures. Dissociation between brain and behavioral measures to reward delivery
would subsequently require a careful reconsideration of neuroeconomic hypotheses. To
date, (pre)clinical studies have shown that mesocorticolimbic areas, such as the striatum,
are activated by cocaine and heroin reward in a similar manner to food rewards
(Cameron, Wightman, & Carelli, 2014; D'Souza & Duvauchelle, 2008; Guillem, Brenot,
Durand, & Ahmed, 2018; Phillips, Stuber, Heien, Wightman, & Carelli, 2003; Risinger et
al., 2005; Saddoris, Wang, Sugam, & Carelli, 2016), but studies have not yet scaled brain
activity with reward-value measures to test neuroeconomic hypotheses.
Invoking ideas of compulsion may also not be necessary to describe dysregulated
drug use, as it is possible that such continued use actually stems from valuation
mechanisms (Heyman, 2013b). Rather than drug use being a habit separate from valuebased decisions, a valuation mechanism would suggest substance abuse is a behavior
allocation disorder (Lamb & Ginsburg, 2018), comprised of competing contingencies in
what commodities produce greater local versus global utility (Herrnstein & Prelec, 1991;
Rachlin, 1997, 2000). For instance, melioration theory suggests drug commodities offer
relatively higher immediate utility than nondrug commodities. Nondrug commodities
may offer more utility in the long term (such as hard work leading to career advancement
or avoidance of job loss), but these consequences are discounted because they are
delayed.
The above depiction of a drug user may appear similar to compulsion theories on
the surface to some, but there are important differences in what mediates regular use. For
a compulsive user, regular use stems from a lack of control where the user is not making
economic decisions and is a static agent. However, the user under melioration theory is
not compulsive and economic decisions are still being made on a local expected utility
basis. The distinction of maintaining a user as an economic agent may seem trivial, but it
has important implications, such as changing the prognosis of treatment from being
necessarily pharmacological to potentially behavioral. Additionally, if drug users do
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maintain economic agency, then understanding how users adapt to changing conditions
may provide new therapeutic targets to adapt behavior away from drug preferences.

Current Dissertation
Dynamic Decisions Across Multiple Dimensions of Reward Value
In order to understand opioid-related decision making, research from behavioral
economics and neuroeconomics has suggested that experiments need to account for the
contextually dependent and relational nature of reward value. Furthermore, experiments
using single-schedule measures common in substance abuse research often do not model
decision making in these more complex environments. The current dissertation therefore
characterized the degree to which opioid-related decision making operates according to a
value-based mechanism through economic drug choice procedures.
Three experiments modeled value-based decision making in rodents based on a
procedure previously used with humans (Rutledge et al., 2009). Experiment 1 validated
the procedure with drug-naïve rats who chose between two probabilistically delivered
food rewards. The reward probabilities of both choices changed in a dynamic,
unpredictable manner, such that maximizing reward intake required constant updating of
reward value based on trial-outcome feedback. Additionally, given that evidence that
reward-associated cues can alter reward value (e.g., Barrus, Cherkasova, & Winstanley,
2015; Zentall & Stagner, 2011), the rats were split between Signaled and Unsignaled
groups. Upon making a choice for either alternative, the Unsignaled group received a
choice-dependent cue that was uninformative of trial outcome; this group served as a
control to represent more commonly used procedures where choices either result in food
reward or food omission without any cues. Alternatively, the Signaled group received
differential reward-associated cues (Smith, Hofford, Zentall, & Beckmann, 2018). Choice
of one option resulted in an uninformative cue similar to the Unsignaled group. However,
choice of the alternative option produced distinct win- and loss-paired cues that were
always followed by reward or omission, respectively. Following sufficient learning of
task contingencies, the reward magnitude was increased for one counterbalanced option
in the Unsignaled group and the option with reward-associated cues in the Signaled
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group. Choice data were then analyzed using molar matching and molecular RL models
to assess economic parameters.
Experiment 2 trained a separate cohort of rats on a probabilistic allomorphic drug
versus food choice by replacing the food reward for one counterbalanced option in the
Unsignaled group and the option with reward-associated cues in the Signaled group with
a self-administered, intravenous infusion of remifentanil (REMI). REMI is a potent μ
opioid receptor agonist (Crespo, Sturm, Saria, & Zernig, 2005) similar to morphine and
heroin (Fields & Margolis, 2015). Three reward magnitudes (i.e., doses) were tested
similar to the three food reward magnitude manipulations in Experiment 1. Finally,
Experiment 3 extended the REMI choice model by recording brain activity in the nucleus
accumbens (NAc), a prominent mesocorticolimbic nucleus in the ventral striatum that is
broadly associated with reward-associated decision making (Salgado & Kaplitt, 2015).
NAc activity was recorded using oxygen-sensitive (O2) microelectrode arrays (MEAs)
implanted into the NAc. The use of O2 increases translational fidelity with fMRI BOLD
measures used in clinical research through a common measure of brain activity.
However, O2 is recognized as a more general measure of activity than other available
alternatives.
Oxygen Measurement and its Relation to Neuron Activity
Oxygen as a measure of neuronal activation is based on cerebral metabolism of
O2 by local cells as well as the cerebral blood flow/volume in the measured area. In fMRI
BOLD signals, oxidative metabolism occurs in a local area that deoxygenizes
hemoglobin. The loss of O2 from hemoglobin then causes co-localized iron to become
paramagnetic and produces a measurable effect on the surrounding magnetic field of
water molecules (Attwell & Iadecola, 2002). However, increases in cerebral blood
flow/volume can exceed deoxygenation in activated areas that often leads to an increase
in net O2 (Ekstrom, 2010).
It has been estimated in primates and rodents that a large proportion of oxygen
changes are related to neuronal activity (Attwell & Laughlin, 2001), but exact activity
specification has not been determined. While spiking is related to cerebral oxygen
responses, post-synaptic events and neurotransmitter release are also thought to
contribute as O2 responses can exceed electrophysiological or local field potential
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measures of neuronal spiking (Attwell & Iadecola, 2002; Buxton, 2012; Ekstrom, 2010;
Sheth et al., 2004). Thus, the current paper will use the general term of “NAc activity.”
Despite being somewhat vacuous, the term NAc activity avoids potential over-attribution
of any one physiological mechanism, save those that are neuronally mediated.
Measuring Oxygen with Microelectrode Arrays
Although rodent fMRI is possible, the necessary immobility of the animal
precludes any ability for behavioral assessment. As an alternative, local oxygen dynamics
can be captured using oxygen-sensitive electrodes in freely moving animals (Lowry et al.,
2010). Electrode amperometry measures of O2 work by applying a constant potential
of -0.6 (vs. reference) that leads to O2 reduction at the surface of the MEA (Li, Schwarz,
& Gilmour, 2015). The reduction occurs in two steps:
O2 + 2H + + 2e− → H2 O2

H2 O2 + 2H+ + 2e− → 2H2 O

and the obtained measure is a change in current induced by electrons transferring from
the MEA to oxygen. Amperometry measures of O2 have high spatial (µm) and temporal
(100 Hz) resolution (Ledo et al., 2017) similar to electrophysiology or voltammetry
measures used in preclinical research while also maintaining an O2-dependent measure
akin to fMRI BOLD signals. Electrochemistry measures of O2 and BOLD are also highly
correlated (Lowry et al., 2010). When compared to rodent fMRI, the time course of fMRI
O2 changes correlates with 99% of variance accounted for by amperometry. Additionally,
amperometry-derived O2 signals show similar functional responses to reward delivery in
the NAc as fMRI studies (Francois, Conway, Lowry, Tricklebank, & Gilmour, 2012;
Francois et al., 2014). Thus, the O2 sensitive electrode recordings can be regarded as a
proxy of fMRI BOLD signals.
An Improved Model of Drug-Associated Value
As previously described, models of substance abuse can be improved by
accounting for the multidimensional and relative nature of a commodity’s reward value.
As such, the current experiments sought to improve upon traditional measures of drugassociated reward value in several ways. First, all measures of reward value were a
relative choice measure. That is, two commodities were always concurrently available
that allowed for a comparison of preference for one option (e.g., Option A) relative to an
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objectively defined alternative (i.e., Option B). Second, reward value was assessed in
more complex, dynamic environments than have historically been used in substance
abuse research. Finally, brain activity was recorded using an O2-sensitive measure that
increased translational fidelity with clinical BOLD measures and was compared to
multiple models of reward value. Together, the present improvements allowed for a more
explicit assessment of whether REMI-associated choices are mediated by value-based or
compulsive decision-making mechanisms.
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CHAPTER 2:
DYNAMIC DECISION-MAKING FOR ISOMORPHIC FOOD VERSUS FOOD
REWARDS
Experiment 1
In the current experiment, decision dynamics were characterized using ‘natural’
rewards (i.e., food) in a probabilistic choice procedure. In doing so, the results of
subsequent experiments assessing drug-associated decision making can be compared
back to the current experiment to avoid misattribution of any potential effects as being
unique to drugs of abuse.
Methods
Subjects
Twelve adult male Sprague-Dawley Rats (Harlan Inc; Indianapolis, IN, USA)
were used in the experiment. Rats were individually housed on a 12:12 hour light:dark
cycle (lights on at 7:00 a.m.) and had free access to water but were food restricted to 15 g
of standard lab chow per day (Harlan Inc.) post session. All research was approved by the
University of Kentucky Institutional Animal Care and Use Committee (Protocol #20110885).
Apparatus
Experiments were conducted in Med Associates (St. Albans, VT) conditioning
chambers (ENV-008) within a sound-attenuating box (ENV-018). On the front panel
inside the chamber were two white jewel lights (ENV-221M) above two retractable
response levers (ENV-122CM) flanking a magazine receptacle (ENV-200R2MA)
equipped with a head entry detector (ENV-254-CB) that received 45-mg sucrose pellets
(BioServ Precision Pellets, Flemington, NJ) from a pellet dispenser (ENV-203M-45).
Directly opposite the levers on the back panel were two nosepoke response receptacles
(ENV-114BM) and a house light (ENV-227M) centrally positioned at the top of the back
panel. All chambers were connected to a personal computer running MED-PC IV
(Tatham & Zurn, 1989).
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Establishing operations
Prior to the experiment proper, rats were pre-trained on four consecutive
procedures: magazine shaping, nosepoke training, nosepoke training with terminal link
stimuli, and orienting responses. During magazine training, rats were placed in the
chamber under a fixed-time (FT) 60-s procedure where a pellet was dropped into the
magazine every 60 s concurrent with the illumination of the house-light for 5 s. Sessions
lasted for 1 hr but only 30 pellets were delivered into the chamber. After all rats ate all
pellets for two consecutive days, the rats were trained to make nosepoke responses.
Sessions began with the illumination of either the left or right nosepoke and was denoted
the initial link of the eventually chained stimuli. A response to the nosepoke would then
offset the receptacle and deliver a food pellet to the magazine. Nosepoke training
consisted of 30 trials (15 left responses, 15 right responses) with the order of left versus
right nosepoke presentation pseudorandomized across trials such that no nosepoke
appeared more than two consecutive trials.
Following two days of completing all trials during nosepoke training, terminal
link stimuli were added to the procedure. During terminal link training, responding to a lit
nosepoke (i.e., the initial link) resulted in the presentation of either the left or right lever
on the front panel for 10 s (i.e., the terminal link), followed by lever retraction and the
delivery of 1 food pellet to the magazine. The spatial counterbalancing of the nosepoke–
lever combinations was consistent to one side of the chamber from the animal’s
perspective; for example, a response to the left nosepoke on the back panel produced the
right lever on the front panel, and vice versa for the other alternative. Here, the lever is
denoted as the terminal link because it is the final stimulus presented prior to reward
delivery. After completing all trials for two sessions, orienting-response training began.
During orienting-response training, illumination of the house-light signaled the beginning
of a trial that required a head entry into the magazine to turn off the house-light.
Following an orienting response (i.e., the head entry to turn off the house-light), either the
left or right nosepoke illuminated in a pseudorandom order, and the procedure continued
as previously described. Orienting-response training continued until all trials were
completed for two days.
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Isomorphic decision-making procedure
After all rats completed the establishing operations, training began on a dynamic
probabilistic decision-making procedure illustrated in Figure 2.1 (Rutledge et al., 2009).
Sessions consisted of four, 30-trial blocks (120 trials total). Each block was characterized
by different relative reward probabilities. The possible relative reward rates, expressed as
Option A:B, were 6:1, 2:1, 1:2, and 1:6 (see Figure 2.1c), and both Option A and B
delivered 1 food pellet for a win trial. As an example, in the 6:1 block, Option A
rewarded choices six times more often than Option B. The reward schedules were
randomized such that the start of the session could begin with any one of the four reward
schedules (i.e., 6:1, 2:1, 1:2, 1:6). After the first block, the determination of remaining
blocks was pseudorandomly determined without repeat such that the choice alternative
with the higher chance of reward (i.e., the “richer” option) switched to the opposite
choice alternative. For instance, if the first block was the 6:1 condition, the second block
was required to be either the 1:2 or 1:6 conditions.
The rats were also split into the Signaled and Unsignaled groups. As shown in
Figure 2.1, the sequence of events following choice of either Option A or B was group
dependent. For the Unsignaled group, choice of either option resulted in the presentation
of an associated lever stimulus for 10 s followed by the probabilistic delivery of 1 food
pellet according to the current reward schedule. For the Signaled group, choice of Option
B was the same as the Unsignaled group. However, choice of Option A produced a lever
stimulus only when a reward was to be delivered (i.e., a win); a white jewel light
illuminated to signal an upcoming loss. The overall reward probabilities for the two
groups were identical. Thus, the only difference between groups was that choices of
Option A for the Signaled group produced a stimulus that was informative of the
forthcoming trial outcome 10 s later, while Option B for the Signaled group and Options
A and B for the Unsignaled group produced stimuli that were not informative of the
upcoming trial outcome. After reward delivery or omission, trials were separated by a 10s intertrial interval (ITI) during which all stimuli were off. Training continued until all
rats significantly decreased their choice of Option A as its relative reward rates declined
for fifteen session. Training lasted for 70 sessions.
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Reward magnitude manipulations
Following initial training, the reward magnitude associated with Option A was
subsequently increased. For the duration of the reward magnitude manipulations, Option
B continued to deliver one sucrose pellet on win trials. However, Option A increased in
reward magnitude to two and three sucrose pellets in Phases 2 and 3, which each lasted
for 10 sessions for both groups.
Data Analysis
Molar choice data
Molar choice data were calculated as the proportion of choices for Option A as a
function of Option A’s relative reward rates averaged over the last five days of training
for each reward magnitude condition. Molar data were then analyzed using three nonlinear derivations of the generalized concatenated matching equation (Equation 7) with
nonlinear mixed effects (NLME; Smith et al., 2018; Young, Clark, Goffus, & Hoane,
2009) models in the NLME package in R (Pinheiro, Bates, DebRoy, & Team, 2016). For
the behavioral data where both options probabilistically rewarded one food pellet,
Equation 14 was used and is referred to as the Generalized Matching equation:
𝐵𝐵𝐴𝐴
=
𝐵𝐵𝐴𝐴 + 𝐵𝐵𝐵𝐵

1

𝑅𝑅 𝑆𝑆𝑅𝑅
1 + � 𝐴𝐴 � ∗ 𝑏𝑏
𝑅𝑅𝐵𝐵

(14)

In Equation 14, BA and BB represent choices for Option A and B, expressed as a function
of the relative reward rates for Option A (RA) and B (RB) multiplied by a bias term (b).
The bias term (b) captures preferences for Option A or B irrespective of the relative
reward rates between the two options. Lower values of b reflect greater bias for Option
A; values close to 1 reflect no bias. SR captures individuals’ sensitivities to changes in the
relative reward rates between Options A and B. Perfect matching between behavior and
relative reward rates would reduce the value of SR to 1.
To account for the later magnitude manipulations, an additional term was added
to the Generalized Matching equation (Equation 14) to capture changes in choice due to
the changes in reward magnitude. Specifically, Equation 15, referred to as the 2Dimensional (2-D) Generalized Matching equation, concatenated the relative reward
magnitudes of Options A and B.
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𝐵𝐵𝐴𝐴
=
𝐵𝐵𝐴𝐴 + 𝐵𝐵𝐵𝐵

𝑅𝑅
1 + � 𝐴𝐴 �
𝑅𝑅𝐵𝐵

1

𝑆𝑆𝑅𝑅

𝑀𝑀 𝑆𝑆𝑀𝑀
∗ � 𝐴𝐴 �
𝑀𝑀𝐵𝐵

(15)

In Equation 15, the relative reward magnitudes for Option A (MA) and B (MB) are raised
to a sensitivity term, SM, that scales how sensitive individuals are to changes in the
relative reward magnitudes.
While Equation 15 does well to describe choice data across individuals choosing
under similar conditions, the current experiment employed group-dependent use of
reward-associated cues not necessarily associated with the dimensions of reward rate or
magnitude. Therefore, should any cue-dependent effects emerge, it is empirically
undetermined how to best quantitatively describe the effects. Some research has
suggested potential cue effects are mediated by enhancing the perceived reward
magnitude of choice alternatives with win-paired cues (i.e., Option A for the Signaled
Group; Smith et al., 2017a; Smith et al., 2018), while others have suggested that choice
alternatives with cues gain value via other dimensions not manipulated here
(Cunningham & Shahan, 2019; Ojeda, Murphy, & Kacelnik, 2018; Trujano, López,
Rojas-Leguizamón, & Orduña, 2016). If potential cue effects are mediated by changes in
subjective reward magnitude, group differences should be captured by the relative reward
magnitude scaling parameter, SM. However, in the case that changes in perceived reward
magnitude are not mediating potential group effects, Equation 16 (2-D Exchange
Matching) can scale reward value differences in terms of Option A and B’s relative
substitutability (Rachlin et al., 1976).
𝐵𝐵𝐴𝐴
=
𝐵𝐵𝐴𝐴 + 𝐵𝐵𝐵𝐵

𝑅𝑅
1 + � 𝐴𝐴 �
𝑅𝑅𝐵𝐵

1

𝑆𝑆𝑅𝑅

𝑀𝑀 𝑆𝑆𝑀𝑀
∗ � 𝐴𝐴 �
𝐸𝐸𝐸𝐸

(16)

In Equation 16, the previous term for Option B’s reward magnitude is replaced by the
scaling constant, Ex. Ex acts an exchange rate for the subjective value of Option B
relative to Option A in units of sucrose pellets. For instance, when the reward magnitude
of Option A is 1, an Ex value of 1 suggests the two options have equivalent reward
magnitudes and are equally substitutable for each other. Values of Ex less than 1 suggest
that Option B is worth less than Option A.
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For all models, Subject was entered in as a nominal random factor, Group as a
nominal, between-subject fixed factor using effects coding, and sensitivity parameters
(i.e., SR and SM) were fit across their relevant dimensions (i.e., relative reward rates and
magnitudes). In order to determine the best-fitting model, model comparisons were
conducted using Akaike Information Criterion (AIC; Symonds & Moussalli, 2011;
Wagenmakers & Farrell, 2004) where smaller values indicate better model fits. When
comparing AIC values between a current and candidate model, changes in AIC values
(∆AIC) ≥ 0 reflect evidence favoring the current model, while 0 ≥ ∆AIC ≥ -2 reflect weak
evidence, -4 ≤ ∆AIC ≤ -7 reflect moderate evidence, and ∆AIC ≤ -10 reflect substantial
evidence for the candidate model. For the current model comparisons, an absolute ∆AIC
of at least 4 was required to select a more complicated candidate model over a simpler
one with fewer free parameters. All parameter estimates, that are negative in the raw
form, are shown as absolute values to aid interpretation.
Reinforcement learning models
In order to test if the results from the molar matching models were applicable at
the molecular level, RL models were fit to characterize the same data as the matching
models at a trial-by-trial resolution. A basic RL model was previously described in
Equations 11-13, but, as Equation 13 was modified to Equation 17 for the current
experiment, the equations are repeated here for convenience:
𝑉𝑉𝐴𝐴𝑡𝑡+1 = 𝑉𝑉𝐴𝐴𝑡𝑡 + 𝛿𝛿𝐴𝐴𝑡𝑡
𝑝𝑝𝑝𝑝ℎ𝐴𝐴𝑡𝑡 =

𝛿𝛿𝐴𝐴𝑡𝑡 = (𝜆𝜆𝐴𝐴𝑡𝑡 − 𝑉𝑉𝐴𝐴𝑡𝑡 )

1+

𝑒𝑒𝑒𝑒𝑒𝑒(−[𝛽𝛽(𝑉𝑉𝐴𝐴𝑡𝑡

−

1

𝑉𝑉𝐵𝐵𝑡𝑡 )]

+ 𝑐𝑐[𝐶𝐶ℎ𝐴𝐴𝑡𝑡−1 − 𝐶𝐶ℎ𝐵𝐵𝑡𝑡−1 ])

(11)

(12)
(17)

In the valuation Equations 11 and 12, the value of Option A (VA), on a given trial, t, is
determined by its current value plus the reward prediction error, δ, or the difference
between the obtained (λA) and expected (VA) reward scaled by the learning rate

parameter, α. Equation 17 then determines the probability of choosing Option A through
a softmax decision rule by scaling the relative value difference of Options A and B
according to the inverse temperature parameter, β. Equation 17 also has the free
parameter c that weights an individual’s tendency to repeat the choice made (Ch) on the
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previous trial (t-1) independently of reward value. ChA equals 1 when the previous choice
was for Option A (i.e., ChB,t-1 = 0), and ChB equals 1 when the previous choice was for
Option B (i.e., ChA,t-1 = 0). Model comparisons began by fitting the Base RL model as
formulated in Equations 11, 12, and 17. The ability of RL models to parameterize rats’
choices was also compared to a Chance model that predicted random choices (i.e.,
probability of choosing A = 0.5).
In order to test if scaling reward magnitude in a similar way as the matching
equations is warranted, the reward prediction error from Equation 12 in a subsequent
Scaled Single-Learning model was modified to Equations 18 and 19:
𝛿𝛿𝐴𝐴𝑡𝑡 = ((𝜆𝜆𝐴𝐴𝑡𝑡 /𝜆𝜆𝑡𝑡𝐵𝐵 )𝑆𝑆𝑀𝑀 − 𝑉𝑉𝐴𝐴𝑡𝑡 )

𝛿𝛿𝐵𝐵𝑡𝑡 = ((𝜆𝜆𝑡𝑡𝐵𝐵 /𝜆𝜆𝐴𝐴𝑡𝑡 )𝑆𝑆𝑀𝑀 − 𝑉𝑉𝐵𝐵𝑡𝑡 )

(18)

(19)

where the obtained reward (λ) for Option A or B is expressed as a ratio relative to the
other option and then raised to the sensitivity to reward magnitude parameter, SM.
Although RL models have traditionally assumed that choices are made by comparing

relative values, valuation functions such as Equations 11 and 12 typically ascribe value to
a commodity independently of others. In Equations 18 and 19, value is instead also said
to be relative to and scaled with other available commodities. For the current experiment,
λA represents the magnitude in units of sucrose pellets for Option A on win trials, while
λB represents either the magnitude for Option B or the exchange rate, Ex, depending on
the outcome of model comparisons from the molar matching models. Conversely, the
ratio of λA and λB is recoded as zero on loss trials.
Subsequent RL models were also assessed that included additional α parameters
dependent on the choice made (Scaled Double-Learning (Option)), the choice’s outcome
(Scaled Double-Learning (Outcome)), or the interaction between choice and outcome
(Scaled Quad-Learning (Option×Outcome)). For instance, given that Option A and B
represent two different signaling conditions for the Signaled group, the weighting of trial
outcomes may not be uniform across choice options. Thus, the three previously
mentioned models were evaluated using model comparison methods that allowed α
values to vary as a function of Options A and B (i.e., αA, αB), choice outcome (i.e., wins
vs. losses; αWin, αLoss ), and wins and losses dependent on the chosen option (αAWin, αALoss,
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αBWin, αBLoss). The fmincon optimization algorithm in MATLAB was used to fit each RL
model to individual rat’s trial-by-trial choice data using maximum likelihood estimation
(Myung, 2003). Model fitting occurred by randomly selecting 100 uniformly distributed
initial starting values constrained on the following intervals: α ∈[0, 1] , β ∈[0, 10], c ∈[-1,
1], and SM ∈[0, 5]. To quantify potential differences among parameters, group effects

were assessed using a series of Wilcoxon rank-sum tests (coded as Signaled-Unsignaled).
In the case that the best fitting model included more than one α, statistical differences
across α parameters were assessed using pairwise Wilcoxon signed-rank tests with
Hochberg corrections for multiple comparisons (Hochberg, 1988). Finally, RPEs

combining all α, group-dependent λ, and SM parameters were calculated when VA and VB
equaled zero as a visual aid to illustrate potential RPE differences across groups.
Results
Molar analysis
Figure 2.2a shows the average proportion of choices for Option A as a function of
Option A’s relative reward rates when the reward magnitude for both options was one
food pellet. Overall, both groups tended to prefer the option providing greater reward
odds (or the “‘richer” option), with preferences being stronger the more disparate the
relative reward rates. In order to quantify the effects of dynamically changing reward
probabilities on choice of Option A, a generalized matching nonlinear mixed-effects
model (NLME; Equation 14) was fit to the data. The model captured the data well, and
results showed that sensitivity to reward rates was significantly higher than zero [F(1, 33)
= 82.18, p < .001]. Both the Signaled [SR = 0.31] and Unsignaled [SR = 0.29] groups
showed comparable [p = .834] decreases in preference for Option A as its relative reward
rate declined. However, as indicated by the parameter values being less than 1, both
groups displayed somewhat shallow decreases in choices relative to the scheduled
changes in relative reward rates. Additionally, the Signaled group [b = 0.65] showed
significantly more bias for Option A than the Unsignaled group [b = 1.05], that showed
very little bias for either option [F(1, 33) = 9.31, p = .005].
Subsequent increases in Option A’s reward magnitude also showed that choices
tended to favor Option A’s increased magnitude (see Figure 2.2b-c). Model comparisons
between different forms of the generalized matching equations are shown in Table 2.1.
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Interestingly, the 2-D Matching Model showed relatively poor fits to the data (not shown)
and was unable to effectively capture the subjects’ data. A global (i.e., equivalent across
groups) exchange rate parameter (Ex) was then added to scale Option B’s reward
magnitude in terms of Option A in the 2-D Global Exchange Matching model. The
inclusion of Ex was beneficial as the AIC value of the 2-D Global Exchange Matching
Model was -17.39 units lower, suggesting substantial evidence in favor of including an
exchange parameter. Finally, when the exchange rate parameter was allowed to vary for
both groups in the 2-D Exchange Matching model, model comparisons again
substantially favored the group-dependent exchange parameter. Overall, the model
comparison results strongly favored selection of the matching models that included a
group-dependent exchange rate parameter.
The absolute value parameter estimates for the final model are shown in Figure
2.3. Similar to initial training, sensitivity to reward rates (i.e., SR) was significantly
greater than 0 [F(1, 127) = 213.26, p < .001] due to decreasing relative reward rates
producing decreases in Option A preferences that were comparable across groups [p =
.405]. Increasing the reward magnitude for Option A also revealed that sensitivity to
reward magnitude (i.e., SM) was significantly greater than 0 [F(1, 127) = 194.10, p <
.001] with a significant effect of Group [F1, 127) = 13.90, p < .001] due to the
Unsignaled group [SM = 1.06)] showing significantly greater sensitivity to the changes in
reward magnitude than the Signaled group [SM = 0.62]. Finally, there was a significant
effect of Group on exchange rates [F(1, 127) = 10.13, p = .002] due to the Unsignaled
group showing comparable exchange between Options A and B [Ex = 1.08], whereas an
unsignaled pellet did not substitute as well for a signaled pellet in the Signaled group [Ex
= 0.54]. Finally, as an example of the scaled differences in reward magnitude between
groups, Figure 2.2d shows the Signaled groups proportion of choices for Option A when
the reward magnitude equaled 1 pellet and the Unsignaled group’s proportion of choices
for Option A when Option A’s reward magnitude equaled 2 pellets. By doubling the
reward magnitude of Option A for the Unsignaled group, the Unsignaled group’s
proportion of choices for Option A approximated the Signaled group’s choice function
when Option A only rewarded 1 pellet.
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Molecular analysis
The molar analyses suggested that Option A’s reward-associated cues for the
Signaled group produced significant alterations in both sensitivity to magnitude and the
exchange rate parameter. If the scaling of the subjective reward magnitude between
Option A and B was indeed a determinant of choice in the current experiment, then
similar effects should appear in the molecular trial-by-trial RL model analysis. Consistent
with the molar results, adding group-dependent exchange rates for Option B’s reward
magnitude from the molar matching model as well as a sensitivity to magnitude
parameter in the Scaled Single-Learning model substantially improved overall fits
relative to the Base RL model (overall ΔAIC = -221.73; see Table 2.2). Adding
additional α learning rate parameters also sufficiently improve model fits when they were
Option-dependent or Outcome-dependent. But, including learning rate parameters that
were both Outcome- and Option-dependent in the Scaled Quad-Learning model was the
overall best fitting model for both groups (Table 2.2).
Figure 2.4a-c shows three example model fits that approximate the average AIC
(± 1 standard deviation). Overall, the RL model successfully parameterized the subjects’
trial-by-trial choices [ΔAIC = -684.42 relative to a chance model] across four levels of
relative reward rates, three levels of relative reward magnitudes, and two levels of
reward-associated stimuli. The parameters from the Scaled Quad-Learning model are
shown in Figure 2.5a. The Signaled group showed (1) significantly higher β values [Z =
2.01, p = .028] indicating a greater tendency to exploit the Option with greater modelderived reward value, and (2) significantly higher α values for Option A losses [Z = 2.20,
p = .028]. However, both groups scaled the changes in reward magnitude in a similar way
and perseverated on choices a similar amount. For within-group tests of the α parameters,
no significant differences were present after correcting for multiple comparisons. Finally,
Figure 2.5b illustrates the calculated RPEs from the Scaled Quad-Learning model. As
suggested by the AIC-warranted group-dependent exchange parameter, the Signaled
group ordinally showed greater updating of reward value for Option A relative to the
Unsignaled group that showed ordinally greater updating of reward value for Option B.
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Discussion
The present experiment sought to establish the dynamic decision-making model
using natural rewards to allow for better interpretation when decisions are made between
allomorphic drug vs. food choices. To that end, this experiment showed that rats
engaging in a randomized probabilistic decision-making procedure could effectively
track the changes in relative reward rates and allocate their decisions appropriately,
similar to monkeys (Lau & Glimcher, 2005) and humans (Rutledge et al., 2009). As
indicated by the significant sensitivity to relative reward rates parameter, rats in both
groups favored Option A when the relative reward rates also favored Option A and then
gradually shifted preferences concurrent with shifting reward rates favoring Option B.
Sensitivity to relative reward rates also showed evident undermatching (i.e., values less
than 1), suggesting possible difficulty in discriminating the randomized relative reward
rates. Indeed, probabilistic decision-making procedures that use consistent ascending or
descending changes in reward probability (e.g., Smith et al., 2018; Yates et al., 2016)
have shown qualitatively sharper preference changes as a function of reward probability
changes. However, both groups in the current experiment still showed a nearly 30%
decrease in preference between the 6:1 and 1:6 relative reward rate conditions, suggesting
the tracking of and appropriate behavioral allocation to relative reward rates.
In addition to changes in relative reward rates shifting choice preferences,
changes in relative reward magnitudes also significantly altered choice patterns.
Specifically, the increase of reward magnitude associated with Option A from 1 to 3
pellets also resulted in an increased preference for Option A similar to previous
experiments (Landon, Davison, & Elliffe, 2003; Marshall, Smith, & Kirkpatrick, 2014;
Neuringer, 1967). Furthermore, the ability of Equation 16, which is an extension of the
generalized concatenated matching equation (Baum, 1974; Rachlin, 1971), to effectively
describe choices provides further evidence that relative reward rates and magnitude can
produce independent effects on behavior (Kyonka, 2008; McLean & Blampied, 2001).
That dimensions of reward value can produce independent effects on choice complicates
the use of other unidimensional scales such as unit price (a ratio of magnitude divided by
cost), as it suggests asymmetric effects when either side of the ratio is manipulated
(Madden et al., 2000; Smith et al., 2016).
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While choices within groups was well characterized, model comparisons revealed
that choice preferences across the Signaled and Unsignaled groups were not accounted
for by sensitivity to changes in either relative reward rates or magnitudes. The inability of
the SM parameter to capture group differences is particularly notable, as previous research
has characterized the effect of reward-associated cues as altering a choice alternative’s
perceived reward magnitude (e.g., Smith et al., 2017a; Smith et al., 2018). However,
previous studies suggesting alterations in reward-magnitude sensitivities only used a
single relative magnitude condition similar to Figure 2.2a. Under such conditions, the
parallel shift in preferences for Option A by the Signaled group is suggestive of a scalar
increase in reward value for that choice alternative such as through a reward magnitude
mechanism. It was not until the current experiment where the assumption of altered
reward magnitude sensitivities, tested through multiple relative reward magnitude
conditions, was coupled with model comparisons so that the hypothesis could be
thoroughly evaluated. The present experiment therefore serves as an exemplar for the
previous statement that models can be “better than mere words” (Mazur, 2006, p. 276), as
the conceptualization of reward-associated cues producing a scalar increase in reward
value is warranted, albeit not via a sensitivity to reward value mechanism as ascribed in
the generalized matching equations.
Seemingly contrary to the model comparison results, the 2-D Exchange Matching
model also showed a significant group effect on sensitivity to magnitude; this effect,
which only appeared in the context of including an exchange rate parameter (Ex), was not
expected and likely did not account for the group differences in other contexts. If
differences in sensitivity to magnitude were the primary determinant of choice
differences between the groups, the 2-D Generalized Matching equation would have
produced better AIC values. Rather, the effect seems to reflect a threshold in how high
rats’ absolute preferences for Option A in both groups can be, which was reached earlier
in the Signaled group due to their starting at a higher preference for Option A at baseline
(i.e., the 1 vs. 1 food pellet condition.). Additionally, the group effect on SM does not
necessarily reflect a violation of matching. Matching assumes that the scaling of a
dimension within a particular context is invariant relative to models which allow
differential scaling parameters for each (e.g., Davison & McCarthy, 1988; Kyonka,
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2008). Stated differently, matching assumes that only one SR value is necessary for all
relative reward rate manipulations. In the present experiment, a single SR and SM
parameter was shown to provide excellent fits to the data, suggesting that the group effect
on SM likely reflected that sensitivities to a reward dimension were context-dependent,
but invariant within one context.
Other research groups have attempted to characterize similar cue effects to that
seen here as being driven by mechanisms of either other reward value dimensions or
cognitive mechanisms. For instance, the temporal information model suggests that the
reason the Signaled group’s reward-associated cues produced preference bias for Option
A was due to the value of having information about forthcoming rewards temporally
sooner than those of choices of Option B (Cunningham & Shahan, 2019; Cunningham &
Shahan, 2018). Alternatively, other models have suggested mechanisms less scalable in
terms of reward dimensionality, such as the reward-associated cues producing a positive
state change between uncertainty to certainty about reward (Case & Zentall, 2018;
McDevitt, Dunn, Spetch, & Ludvig, 2016). Although the present experiment cannot
discern these proposed mechanisms, the phenomenon of reward-associated cues biasing
choice is robust and present across a number of species (Blanchard, Hayden, &
Bromberg-Martin, 2015; Iigaya, Story, Kurth-Nelson, Dolan, & Dayan, 2016; Molet et
al., 2012; Smith et al., 2018; Smith, Beran, & Young, 2017b; Vasconcelos, Monteiro, &
Kacelnik, 2015; Zentall, 2016).
Equation 16 offers another way to quantitatively describe the effect of rewardassociated cues in terms of substitutability (Green & Freed, 1993) through the exchange
rate parameter. Substitution is defined as the degree to which consumption of an
alternative commodity changes as the cost or magnitude of the present commodity
changes. For the present experiment, as the relative reward rates stopped favoring Option
A, choices of Option B increased for both groups; this is substitutability. Conversely,
some rewards, such as food and water, are less substitutable and increases in the price of
one do not necessarily engender greater consumption of the other (Green & Rachlin,
1991; Rachlin et al., 1976). In the present experiment, the exchange parameter revealed
that Option B (an unsignaled and probabilistic food reward) was more substitutable for a
similarly unsignaled and probabilistic food reward (Option A in the Unsignaled group).
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However, Option B was less substitutable for Option A in the Signaled group, even
though Option A offered the same reward commodity (food) but with an informative
signal for reward. The results therefore suggest that a Pavlovian cue altered the
substitutability between two otherwise equivalent operant rewards (Barrus et al., 2015)
and confirm the earlier conceptualization that a signaled alternative produces a scalar
increase in reward value, albeit not through a sensitivity to reward magnitude mechanism.
The results of the matching equations revealed many findings relevant to rats’
dynamic decision-making. However, the matching equations offer a molar view of the
potential mechanisms at work. If a scalar difference in the substitutability between
options A and B accounted for group differences, the effect should also be present at the
molecular trial-by-trial level as assessed by an RL model. Indeed, as suggested by the
model comparison results shown in Table 2.2, the addition of group-dependent exchange
parameters and sensitivity to magnitude terms (Scaled Single-Learning model)
substantially improved the fits relative to the Base RL model; this result suggests that a
scalar difference in reward magnitude between options and across groups is present at
both molar and molecular levels of decision making. Traditionally, RL models have
assumed that the value updating of each commodity is scaled independently of one
another (e.g., Groman et al., 2017; Marshall & Kirkpatrick, 2017; Rutledge et al., 2009)
and that choices between commodities are only relative in the sense that values between
commodities are compared in the decision rule. The present finding of improved model
fits through altering the RL valuation equations by way of relative magnitude scaling
suggests that the independence of value assignment is incorrect. One possible reason for
the traditional use of independent value scaling may stem from many RL models being
implemented to model behavior in isomorphic choice procedures. However, the finding
that value updating is not independent of the other available commodities is congruent
with the matching assumption that preference for a reward is at least partially driven by
how that reward compares to other available commodities.
One of the further benefits of molecular analyses, such as those using RL, is that
they can be more modular in terms of what proposed mechanisms can be incorporated.
For the present experiment, it was hypothesized that wins and losses may be scaled
differentially across options and groups in addition to the scalar differences in reward
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magnitude. To test the hypothesis that wins and losses scaled differentially, additional α
parameters were added into the model in three steps as dependent upon Option, Outcome,
and their interaction. As evidenced by the change in AIC parameters across models, the
inclusion of α parameters for the interaction between Option and Outcome was
substantially warranted in both groups. The results of the best fitting model suggested
that the Signaled group had significantly higher β parameters and scaling of loses for
Option A. The increased β values suggest the Signaled group was more “on policy” and
made choices more closely in line with the model-derived reward values (Gläscher et al.,
2010; Marshall & Kirkpatrick, 2017). Interpretation of the increased scaling of Option-A
is not readily apparent in isolation, but the general finding that wins and losses were
scaled differently has been shown previously (Estle, Green, Myerson, & Holt, 2006;
Kahneman & Tversky, 1979; Marshall & Kirkpatrick, 2013) and reinforces the notion
that decisions are contextually-dependent. That more group effects were not present may
also have been due to the inclusion of group-dependent exchange parameters in the
Scaled Quad-Learning model. Once included, the RL models for each group would then
solve for the remaining parameters with a group effect already built into the model. Thus,
one interpretation of the absence of group effects is that the group-dependent exchange
rates largely captured the variance associated with group differences.
Although no significant differences between α parameters were apparent within
groups, the AIC values for the Scaled Quad-Learning model substantially favored their
inclusion and the medians shown in Figure 2.5a do suggest variability in α scaling. The
dissociation between model comparisons and traditional null hypothesis significance
testing (NHST) also represents a crossroad in the field as the two types of analyses
potentially ask fundamentally different questions (Symonds & Moussalli, 2011;
Wagenmakers & Farrell, 2004). The present experiment combined both methods and,
until the RL model, both analyses were concordant. The model comparison results
suggest that inclusion of α values dependent on the interaction between Option and
Outcome substantially improved the model’s ability to predict an individual rat’s choices.
Alternatively, the non-parametric tests suggest that, at a group level, there was no
systematic variation in how the α estimates were ranked across rats. While the “correct”
analysis is likely not objectively able to be defined, model comparison approaches are
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becoming the increasingly recommended analysis approach given their ability to answer
research questions in a more flexible manner (Symonds & Moussalli, 2011;
Wagenmakers & Farrell, 2004). The present study may also have been under powered to
detect parameter differences using nonparametric methods. In order to analyze the
remaining parameters via a model comparison method, each parameter would need to be
fit at the group level similar to the molar analyses. However, the inclusion of group-level
parameters in RL models is complicated by parameter fits being uniquely path-dependent
for each subject (Daw, 2011). The exchange rate parameters were able to be fixed
because they were informed from the molar matching models while no other parameter
was similarly informed. As such, the necessity of performing second level analyses on
RL parameters remains a limitation of the model (Marshall & Kirkpatrick, 2017;
Rutledge et al., 2009). A final consideration when interpreting the parameters from RL
models is that no single parameter in isolation is fully informative of how decisions are
made in the context of an RL model; that is, Figure 2.5b illustrated how the different
parameters come together to determine value and showed the expected ordinal directions
of Option A having greater value updating for the Signaled group relative to the
Unsignaled group.
Overall, Experiment 1 suggests that rats behaved as if their decisions were valuebased when choosing between two food rewards that varied as a function of both relative
reward rates and magnitudes. Additionally, the presence of reward-associated cues in the
Signaled group biased choice towards Option A. Although the interpretation of RL
parameters is limited by both the structure of the model and the current experiment’s
statistical power, the molar matching analyses provided an excellent description of the
data that was supported in the RL models.
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Table 2.1. Experiment 1 molar models.
Equation

Model Name

Parameter
Parameters
Count

15

AIC

ΔAIC

2-D Matching
2
SR, SM
-262.96
-2-D Global
16
Exchange
3
SR, SM, Ex -280.35 -17.39
Matching
2-D Exchange
16
4
SR, SM, Ex -315.61 -35.26
Matching
Note: Models are shown in descending order of AIC values. ΔAIC calculations are
shown as the difference from the previously best fitting model. Bolded text indicates the
best overall fitting model.
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Table 2.2. Experiment 1 molecular models.
Model

Parameter
Count

Parameters

Signaled
AIC

Signaled
ΔAIC

Unsignaled Unsignaled
AIC
ΔAIC

Base

3

α,β,c

2045.45

--

2165.65

--

Scaled Single-Learning
Scaled Dual-Learning
(Outcome)
Scaled Dual-Learning
(Option)
Scaled Quad-Learning
(Option×Outcome)

4

α,β,c,SM

1698.46

-349.99

2072.18

-93.47

5

αWin,αLoss,β,c,SM

1696.59

-1.87

2064.43

-7.75

5

αA,αB,β,c,SM

1651.23

-45.36

2058.09

-6.34

7

αAWin,αALoss,αBWin,αBLoss,β,c,SM

1579.65

-71.58

2042.17

-15.92
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Note: Models are shown in descending order of overall average AIC values. ΔAIC calculations are shown as the difference from the
previously best fitting model. Bolded text indicates the best overall fitting model.

Figure 2.1. Experiment 1 general methods. (a) Sequence of events during initial training
for the Signaled group. (b) Sequence of events during initial training for the Unsignaled
group. The reward magnitude manipulations subsequently increased the reward
magnitude for Option A to two and then three pellets. * indicates that all stimuli offset
following the event. (c) The probabilities of events and the relative reward rates (defined
as the reward probability for Option A / Option B) for Option A and B.
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Figure 2.2. Experiment 1 molar choice data. (a) Mean (± SEM) proportion of choices for
Option A as a function of Option A’s relative reward rates for the Signaled and
Unsignaled groups during initial training. Lines are the NLME-determined best fits of
Equation 14. (b) Mean (± SEM) proportion of choices for Option A as a function of
Option A’s relative reward rates for the Signaled group during the magnitude
manipulations. 1-1, 2-1, and 3-1 refer to the scheduled reward magnitude for Options A
and B, respectively. Lines are the NLME-determined best fits of Equation 16. (c) Mean
(± SEM) proportion of choices for Option A as a function of Option A’s relative reward
rates for the Unsignaled group during the magnitude manipulations. Lines are the NLMEdetermined best fits of Equation 16. (d) Mean (± SEM) proportion of choices for Option
A as a function of Option A’s relative reward rates for the Signaled group during the 1-1
magnitude condition and the Unsignaled group during the 2-1 magnitude condition. Lines
are the NLME-determined best fits of Equations 14 and 16 for the Signaled and
Unsignaled group, respectively. Note: x-axes are logarithmic for visualization.

47

Figure 2.3. Experiment 1 molar parameter estimates. Mean (± SEM) parameter
estimates from the NLME model of Equation 16 to the molar choice data during the
magnitude manipulations in Experiment 1. Abs = absolute value transform. Note: error
bars represent the between-subject variability of the predicted parameters. A lack of error
bars reflects no differential predictions across rats for the relevant parameter.
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Figure 2.4. Experiment 1 RL model fits. Example Scaled Quad-Learning model fits to
individual rat’s choices of Option A. Dashed vertical lines represent reward magnitude
changes for Option A in order of 1, 2, and 3 food pellets. Panels show (a) a Signaled rat
one SD below, (b) a Signaled rat at, and (c) an Unsignaled rat one SD above the average
AIC. All data were smoothed with an 11-trial moving average.
49

Figure 2.5. Experiment 1 molecular parameters. (a) Median parameter estimates from the
Scaled Quad-Learning model to the molecular choice data in Experiment 1. Medians are
shown due to the use of nonparametric test statistics, and error bars represent the
interquartile range. Note: β values are scaled according to the second y-axis at the right.
(b) Mean (± SEM) predicted reward prediction errors (RPEs) from the Scaled QuadLearning model for Option A and B in the Signaled and Unsignaled groups as a function
of Option A’s reward magnitude. The displayed RPEs are from equations 18-19 when VA
and VB equaled zero.
50

CHAPTER 3:
DYANMIC DECISION-MAKING FOR ALLOMORPHIC OPIOID VS. FOOD
REWARDS
The results from Experiment 1 validated what to expect using the present dynamic
decision-making model in drug-naïve rats responding for natural rewards. Namely, rats
showed significant choice alterations between concurrently available commodities that
were dependent upon the relative reward rates, relative reward magnitudes, and the
presence versus absence of reward-associated cues. In the current experiment, the same
isomorphic food versus food procedure was initially trained as in Experiment 1, but, after
sufficient training, the food reward associated with Option A was replaced by different
doses of an intravenous infusion of the opioid μ receptor agonist remifentanil (REMI). If
choices for drug reward are indeed a reflection of a disorder of choice, then choices
between REMI and food should show comparable effects to that of Experiment 1.
However, if drugs of abuse instead transition an agent from making economic decisions
to one of compulsive drug preference (e.g., Kalivas et al., 2005; Volkow et al., 2016;
Wise & Koob, 2014), then repeated experience with REMI should result in inflexible
choices for drug that do not vary systematically with the experimenter-manipulated
variables.

Experiment 2
Methods
Subjects
Sixteen adult male Sprague-Dawley Rats (Harlan Inc; Indianapolis, IN, USA)
were used in the experiment. Rats were individually housed on a 12:12 hour light:dark
cycle (lights on at 7:00 a.m.) and had free access to water but were food restricted to 15 g
of standard lab chow per day (Harlan Inc.) post session. All research was approved by the
University of Kentucky Institutional Animal Care and Use Committee (Protocol # 20110885).
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Apparatus
The apparatus was the same as Experiment 1 with the addition of an infusion
pump (PHM-100) attached to the outside of the sound-attenuating chamber. A syringe
was loaded into the pump and delivered drug through tubing inside of a metallic leash
(PHM-110-SAI) that was attached to a swivel above the operant chamber. The rate of
infusion delivery was 0.1 mL / 5.9 s.
Drugs

Remifentanil hydrochloride gifted from the National Institute on Drug Abuse

(Bethesda, MD, USA) was mixed in sterile saline (0.9% NaCl).
Establishing operations
All establishing operations were identical to Experiment 1.
Isomorphic food versus food choice
Following establishing operations, the rats were trained on the same isomorphic
dynamic decision-making procedure described in Experiment 1 and were split into
Signaled and Unsignaled groups prior to training. The reward magnitudes for both
Option A and B were 1 sucrose pellet and training continued for 70 sessions.
Catheter surgery
Following training on the isomorphic procedure, rats underwent surgery for
implantation of a chronic, indwelling jugular catheter. Rats were anesthetized with a
mixture of ketamine (Schein, Dublin, OH), xylazine (Akorn, Inc. Decatur, IL), and
acepromazine (Boehringer Ingelheim, St. Joseph, MO; 75/7.5/0.75 mg/kg) delivered at
0.15 mL/100 g body weight (i.p.). The catheters were inserted into the jugular vein,
extended under the skin, and exited the body via an incision on the back attached to a
cannula. All animals were given 7 days to recover after surgery.
Drug self-administration training
After recovery, the rats were trained to self-administer a 3 μg/kg infusion of
REMI. For both groups, Option A became associated with the REMI reward and was
counterbalanced between the left and right nosepoke across animals. At the beginning of
a session, the drug-associated nosepoke on the back panel illuminated and, after one
response, the nosepoke’s associated lever on the front panel extended into the chamber.
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The lever remained extended for 10 s and the 3 μg/kg infusion began at 8.23 s into the
interval and finished after 1.77 s concurrent with lever retraction. Trials were separated
by a 10-s ITI. Sessions lasted for 1 hr, and training continued until all rats administered at
least 10 infusions for two consecutive days.
Food versus drug training
Following initial training, sessions began by the illumination of the house-light,
that required an orienting response to the magazine. Once an orienting response was
made, the house light was offset and either the drug-associated Option A nosepoke or the
food-associated Option B nosepoke illuminated on the back panel of the chamber. After a
single response, the associated lever extended into the chamber for 10 s and an infusion
of REMI or delivery of a food pellet occurred as previously described. Training
continued until all rats finished all trials for two consecutive sessions.
Allomorphic drug versus food procedure
After training to self-administer both REMI and food, rats chose between a
probabilistic REMI and probabilistic food reward in the same manner as described in
Experiment 1. The only exception was that choice of Option A delivered a 3 μg/kg
infusion of REMI rather than a sucrose pellet, such that the infusion completed
concurrently with the offset of Option A’s associated terminal-link stimulus. All rats
were trained for a maximum of 10 days on the 3 μg/kg dose but, if a subject’s average
proportion of choices for Option A over five days significantly decreased as a function of
Option A’s relative reward rates, could be moved on to other doses after 7 days.
Reward magnitude manipulations
After training on the initial 3 μg/kg dose, the reward magnitude for Option A was
changed to either 10 μg/kg or 1 μg/kg in a counterbalanced fashion. Half of the rats from
each group first experienced the 1 μg/kg dose and then 10 μg/kg and half in the opposite
order. Dose was manipulated by changing the pump delivery time. For the 10 μg/kg
condition, the pump turned on 4.1 s into the 10 s terminal link interval while the pump
turned on 9.41 s into the 10 s interval for the 1 μg/kg condition. All infusion times
finished at the end of the 10 s interval concurrent with terminal link stimulus offset. Each
dose was trained for a total of 10 sessions prior to moving on to the next dose.
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Data Analysis
Molar analysis
Data analysis for the present Experiment closely followed Experiment 1. Choice
behavior was calculated as the five-session average proportion of choices for Option A as
a function of Option A’s relative reward rates. The data were again analyzed using the
NLME package in R and took the form of the same three derivations of the generalized
matching equations (Equations 14-16) with the exception that the continuous factor of
magnitude was replaced by the continuous factor of dose in μg/kg. For the initial
isomorphic training, where both options offered food reward, the generalized matching
equation was used (Equation 14), and model comparisons were conducted on the
allomorphic drug vs. food procedure similar to Experiment 1. Namely, potential effects
of Option A’s reward-associated cues were quantified as altering subjects’ sensitivity to
changes in dose (SM; Equation 15) or through differences in exchange rates (Equation
16). Here, the exchange rate parameter, Ex, scaled the reward magnitude of Option B in
units of a μg/kg REMI infusion. For all analyses of drug self-administration, the data
represent the average of the last five days of training for the condition.
The same sessions were also used to calculate the average interchoice intervals
(ICI), or the time between choices as a function of dose. ICIs as a function of increasing
doses have been shown in the literature to monotonically increase for different drugs of
abuse (Beckmann et al., 2019). The present analysis sought to confirm a monotonically
increasing function of ICIs with dose. ICIs were analyzed for all trials and also for trials
only following REMI-Wins (i.e., Option A) as a function of dose using a linear mixed
effects (LME) model in JMP with Subject as a nominal random factor, Group as a
nominal fixed factor, Trial Type as a nominal fixed factor, and Dose as a continuous
fixed factor. All continuous variables were mean centered.
Molecular analysis
Molecular analysis closely followed Experiment 1. However, for all models, λA
represented the reward magnitude for Option A in REMI μg/kg units, while λB
represented either the magnitude for Option B in food pellets in the Base RL model or the
exchange rate parameter, Ex, scaled in REMI μg/kg units in subsequent models.
Following analysis of the Base RL model, the reward prediction error term of Equations
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18 and 19 were again expressed as a ratio of each option’s relative reward magnitude
raised to the sensitivity to magnitude parameter (SM). On loss trials, the ratio was recoded
as zero. Subsequent models were also assessed that included additional α parameters
dependent on either Option (A vs. B), Outcome (win vs. loss), or the interaction between
Option and Outcome. All models were again fit using the fmincon optimization algorithm
in MATLAB using the same parameter constraints and log likelihood measures as
Experiment 1. The overall best fitting model was determined according to the lowest AIC
value. To quantify any potential differences between parameters, a series of Wilcoxon
rank-sum tests were conducted across parameters. In the case that the best fitting model
included more than one α, statistical differences across α parameters were assessed using
pairwise Wilcoxon sum-rank tests with Hochberg corrections that included the relevant
factors of Option, Outcome, and their interaction, depending on the best fitting model.
Finally, as a visual aid to illustrate the differences in RL modeled reward magnitudes,
RPEs were calculated for both options across groups.
Results
Molar analysis
Figure 3.1a shows the proportion of choices for Option A as a function of Option
A’s relative reward rates during the isomorphic food versus food procedure. Similar to
Experiment 1, both groups tended to prefer the option with higher overall reward rates.
Using dummy coding for the Group factor (due to non-convergence with effects coding),
the NLME generalized matching equation again fit the data well. Results from the NLME
model showed significant sensitivity to relative reward rates [SR = 0.26; F(1, 45) = 65.75,
p < .001] for the Unsignaled group, with significantly greater sensitivity in the Signaled
group [SR = 0.44; F(1, 45) = 13.83, p = .001]. The Unsignaled group also showed
relatively little bias for either alternative [b = 1.16], while the Signaled group showed
significantly more bias for Option A [b = 0.59; F(1, 45) = 12.10, p = .001]. Overall, the
results showed that rats in both groups were making choices based on relative reward
rates prior to catheter surgery, and the Signaled group again showed a bias for Option A’s
reward-associated cues.
For allomorphic REMI vs. food choice, Figure 3.1b-c shows the Signaled and
Unsignaled group’s proportion of choices for Option A as a function of Option A’s
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relative reward rates and REMI dose. Similar to the isomorphic procedure, allomorphic
choices showed apparent control by both reward dimensions. That is, preferences shifted
as both the relative reward rates and relative reward magnitudes changed. Additionally,
the Signaled group showed an apparent bias for REMI reward at all doses.
Three different models were compared with the results shown in Table 3.1. Similar to
Experiment 1, the 2-D Matching Model showed relatively poor fits that were improved
by adding a global exchange parameter. However, allowing the exchange parameter to
vary as a function of group revealed that the 2-D Exchange Matching model was
substantially favored as the best fitting model. The parameter estimates (Figure 3.2) from
the best fitting model also corroborated the apparent trends in the data. Both the Signaled
[SR = 0.29; SM = 1.12] and Unsignaled groups [SR = 0.21; SM = 1.10] showed comparable
decreases in drug preferences as the reward rates began to favor food [F(1, 171) = 19.8, p
< .001] and significantly altered their choices depending on drug doses [F(1, 171) =
147.38, p < .001]. Results also showed a significant Group effect on the exchange
parameter [F(1, 171) = 11.90, p = .001], indicating that Option B had greater relative
worth in units of a REMI μg/kg infusion for the Unsignaled group [Ex = 5.86] than the
Signaled group [Ex = 3.16].
Figure 3.3 shows the average ICIs for all trials as well as only trials following
REMI-Wins. Analysis revealed that ICIs significantly increased with dose [F(1, 14) =
16.93, p < .001], ICIs following REMI-Wins were longer overall [F(1, 14) = 52.97, p <
.001], ICIs following REMI-Wins increased as a function of dose more rapidly than
overall ICIs [F(1, 14) = 17.14, p < .001], and that ICIs were comparable between groups.
Molecular analysis
The molar analyses supported the use of a group-dependent exchange rate
parameter and suggested that scaling the valuation term in RL models as relative reward
magnitude ratios may also improve overall fits. Indeed, changing RL valuation equations
to a scaled ratio of relative reward in the Scaled Single-Learning model showed
overwhelming evidence of improved fits (overall ΔAIC = -348.73; Table 3.2). Including
additional α parameters dependent on Option and Outcome also showed substantial
improvements in model fit. However, as in Experiment 1, adding α values dependent on
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the Option × Outcome interaction in the Scaled Quad-Learning model was the best fitting
model.
Figure 3.4 shows three example model fits that approximate the average AIC (±
one standard deviation). Overall, the RL model successfully parameterized the subjects’
trial-by-trial choices [ΔAIC -640.60 from a chance model] across all manipulated
variables despite its foundation in conditioning principles for non-drug commodities.
Parameters from the Scaled Quad-Learning model are shown in Figure 3.5a. There were
no significant group effects on any parameter, but α values for wins were significantly
higher than losses across both options for the Signaled [Z = 2.52, p = .012] and
Unsignaled groups [Z = 2.52, p = .012]. Finally, Figure 3.5b shows the calculated RPEs
for win trials when the current value for both options equaled 0. As in Experiment 1, the
calculated RPEs showed the expected ordinal effects of the Signaled group showing
greater value updating for Option A than the Unsignaled group that showed greater value
updating for Option B.
Discussion
The purpose of Experiment 2 was to assess the ability of rats to make value-based
decisions when choosing between probabilistic drug and nondrug rewards. To that end,
the results strongly support that rats in the present experiment were making decisions
between REMI and food as if they were value-based. Rats in both groups showed
significant sensitivity to relative reward rates as evidenced by decreasing choices for
REMI when the reward rates favored food (i.e., Option B). Additionally, as the dose of
REMI increased, so did choices for REMI. Finally, the Signaled group’s rewardassociated cues produced a significant bias for REMI across all reward rate and
magnitude conditions but otherwise did not alter the effects of changes on those
dimensions to allomorphic decision-making.
Prior to the allomorphic procedure, it was important to ensure that rats, during the
isomorphic procedure, showed sensitivity to relative reward rate changes similar to
Experiment 1. Without replicating the effects of Experiment 1, any potential deficits seen
in allomorphic drug-associated decision making could be attributed to an overall lack of
learning. However, rats in the current experiment’s isomorphic procedure showed
significant sensitivities to relative reward rates. Interestingly, the present experiment also
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showed that the Signaled group had heightened sensitivities to relative reward rates
compared to the Unsignaled group. Although unexpected, the increased SR values may be
interpreted in a manner similar to the group differences in sensitivity to reward
magnitude from Experiment 1. That is, sensitivities to a given dimension are likely to be
contextually dependent such that the two groups, through the differential use of rewardassociated cues, made decisions in different contexts. The increased SR values may also
be interpreted from the perspective of differential outcomes research (Urcuioli, 2005),
that has shown improved discrimination learning when two choices lead to either
different stimuli or rewards.
After sufficient training on the isomorphic condition, the rats were moved on to
the allomorphic drug versus food condition to assess if they could make value-based
allomorphic decisions. Indeed, contrary to compulsion hypotheses of addiction (e.g.,
Kalivas et al., 2005; Wise & Koob, 2014), replacing Option A’s associated food reward
with varying REMI doses revealed that choices for REMI were sensitive to both the
relative reward rates and magnitudes of the concurrently available options. That rats were
sensitive to reward magnitude (i.e., dose) corroborates previous research using REMI and
other opioid μ receptor agonists (Freeman & Woolverton, 2011; Koffarnus & Woods,
2008; Negus, 2006; Spiga, Maxwell, Meisch, & Grabowski, 2005), and the dosedependent increase in the average ICIs parallels previous procedures assessing cocaine
choice (Beckmann et al., 2019). However, the present study is believed to be the first to
show that choices of an opioid μ receptor agonist are sensitive to relative reward rates,
thus corroborating findings with cocaine choice (Woolverton & Rowlett, 1998).
Experiment 2 also showed that relative reward rates and magnitude produce independent
effects on REMI choices in line with the predictions made by the matching literature
(e.g., Kyonka, 2008) outlined in Experiment 1. Namely, a single sensitivity parameter for
relative reward rates and magnitudes sufficiently described the data. Further, the average
parameter estimates for sensitivity to relative reward rates were similar between the
current experiemnt (mean SR = 0.25) and Experiment 1 (mean SR = 0.30), suggesting that
the dimensional control exerted by the relative reward rates was comparable between
isomorphic food-food and allomorphic drug-food decision-making conditions.
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Also similar to Experiment 1, the Unsignaled group made decisions as if Option
B’s reward magnitude was larger (Ex = 5.86) than the Signaled group (Ex = 3.16) despite
choice of Option B resulting in an identical reward magnitude (i.e., one food pellet).
Scaled in units of a REMI μg/kg infusion, the group effect on the exchange rate
parameter suggests a scalar difference in how substitutable (Green & Freed, 1993) an
unsignaled food pellet is relative to an unsignaled REMI infusion (for the Unsignaled
group) or a signaled REMI infusion (for the Signaled group). Thus, whether choosing
between identical rewards (Experiment 1) or qualitatively different rewards (current
experiment), the reward-associated cues produced a similar effect on how substitutable
Options A and B are for one another. The present experiment is also believed the first to
show that reward-associated cues as used here can bias choice for drug reward and
corroborates previous research using food rewards (Zentall, 2016) as well as research
showing that conditioned stimuli can alter the value of drug rewards (e.g., Beckmann et
al., 2019; Tunstall & Kearns, 2014).
Given that the molar data were suggestive of a scalar difference in reward
magnitude between REMI and food across the two groups, the molecular RL analysis
sought to confirm the finding at a trial-by-trial level. As in Experiment 1, the RL model
comparisons supported scaling the valuation equations as a ratio of relative reward
magnitudes that included a group-dependent exchange term and sensitivity to reward
magnitude parameter. As discussed in Experiment 1, the implications of altering the RL
valuation equations from independent to relative reward magnitude represents an
important difference from traditional RL models that only recognize the relative nature of
choice preferences in the decision equation. The current experiment extends upon
Experiment 1 by providing a replication of the effect in allomorphic choice conditions.
Additionally, for the same reasons as Experiment 1, the lack of any group effects on RL
parameters may not be without cause. That is, inclusion of group-dependent exchange
terms in the Scaled Quad-Learning model effectively builds a group effect into the model
around which the remaining parameters may optimize. Therefore, once the scalar
differences in reward magnitude of the two options are accounted for, other decision
parameters may have become somewhat consistent.
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The RL model also extends the results of the molar matching models through its
ability to scale wins and losses with the α parameters. As in Experiment 1, the inclusion
of additional α parameters was beneficial for model fits according to AIC differences,
and the non-parametric tests showed that wins were weighted significantly more than
losses for both alternatives in both groups. That wins and losses were differentially scaled
suggests there was variance in how rats in the present experiment made decisions that
went beyond what was captured by the reward magnitude differences across options
(Kahneman & Tversky, 1979; Marshall & Kirkpatrick, 2017). Additionally, it is believed
that the present experiment is the first to apply RL models to drug choices in any species
and among a minority that do so for rodent choice data (e.g., Groman et al., 2017;
Marshall & Kirkpatrick, 2017). The finding that an RL model can successfully
parameterize drug choices is a significant finding, as RL models imply that an agent is
calculating expected payoffs and adjusting future choices accordingly. Such value-based
decision-making is certainly not something one would expect from a compulsive drug
user.
In terms of the current result providing a satisfactory test of compulsive drug use
hypotheses, two potential limitations were the choice of drug and whether or not the
current rats represented “addicted” individuals. Indeed, although REMI is an opioid μ
receptor agonist similar to other abused opioids (Glass et al., 1993; SAMHSA, 2017;
Trescot, Datta, Lee, & Hansen, 2008), its relatively short half-life (Crespo et al., 2005;
Glass et al., 1993; Haidar et al., 1997) is thought to contribute to a lower abuse liability
(Baylon, Kaplan, Somer, Busto, & Sellers, 2000). However, as clearly evidenced by rats’
choices in the present experiment, REMI has reinforcing efficacy. Furthermore, at least
one abuse case of REMI exists in humans (Levine & Bryson, 2010). Future research
could therefore expand upon the current experiment through use of other opioid μ
agonists.
As to whether the present rats represent “addicted” individuals, the allostatic
theory of drug addiction (e.g., Wise & Koob, 2014) suggests that choices for a drug are
initially driven by the positive reward value of such drugs of abuse. After repeated
administrations, tolerance to the pharmacological effects develop that both diminish the
drug’s positive rewarding value and alters the individual’s biological homeostatic set
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point. During this later stage of addiction (i.e., tolerance), drug use is driven to maintain
the new homeostasis point reliant on the drug’s presence and to avoid the associated
withdrawal consequent upon failure to maintain drug use. Ultimately, the result is that the
user transitions from voluntary to compulsive use where drug taking occurs
independently of the drug being hedonically pleasing. In rats, the transition to compulsive
use is ostensibly modeled using the previously described escalation procedures (Ahmed
& Koob, 1998; Lenoir et al., 2013), where rats who are given extended access to a drug
show increased levels of drug consumption when offered in isolation.
That the present rats did not undergo an escalation of drug intake procedure prior
to making allomorphic choices may suggest that the current rats simply do not meet the
criteria for addiction. However, the suggestion that individuals are only compulsive when
they are addicted is a cyclical mode of thinking that precludes hypothesis testing of
addiction theories. Additionally, evidence that escalation of drug intake reflects
dysregulated and compulsive drug use remains speculative. Choice preferences for
stimulants after evidence of escalation remains unchanged (Caprioli et al., 2015; Lenoir
et al., 2007), and there is only one report showing that preferences for heroin increases
after escalation (Lenoir et al., 2013). Furthermore, although escalation commonly shows
that drug intake during a short-access period (i.e., 1 hr) is regulated (i.e., does not
escalate), rats who are first acclimated to a 10-min self-administration period have shown
escalation during a subsequent 1-hr self-administration session (Beckmann, Gipson,
Marusich, & Bardo, 2012). Rats have also shown evidence of escalating food
consumption (Goeders, Murnane, Banks, & Fantegrossi, 2009; Venniro, Zhang, Shaham,
& Caprioli, 2017), and training rats on an escalation procedure prior to an allomorphic
decision-making procedure produces a strongly biased reward history that is often not
acknowledged (Beckmann et al., 2019). Additionally, although there is mixed evidence
indicating that animals experiencing opioid withdrawal (i.e., a marker of biological drug
dependence) show increased drug preferences (Lenoir et al., 2013; Negus, 2006; Negus
& Rice, 2009), rats who have been acutely deprived of food will also show increased
food preference and hoarding (Beckmann et al., 2019; Morgan, Stellar, & Johnson,
1943). Thus, the ostensible behavioral markers of dysregulated drug use may instead
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reflect general learning and behavioral mechanisms that do not discredit rats’ value-based
decision-making for a REMI food reward in the present experiment.
To summarize, the current experiment revealed several findings relevant to our
understanding of drug abuse. First, choices for REMI were shown to be dependent upon
both the relative reward rates and magnitudes of the concurrently available commodities.
Second, the presence of conditioned stimuli associated with REMI reward significantly
biased decision making towards REMI choices in a manner similar to stimuli being
paired with food reward. Third, the allomorphic choice dynamics were able to be
captured at both the molar level with matching models and the molecular level with RL
models. Finally, the present experiment (1) suggests that rats are indeed capable of
making value-based decisions for drug commodities and (2) establishes a basic procedure
from which to test further decision-making hypotheses in a more dynamic procedure than
is typical in substance abuse research.
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Table 3.1. Experiment 2 molar models.
Equation

Model Name

Parameter
Parameters
Count

AIC

ΔAIC

15

2-D Matching
2
SR, SM
-148.71
2-D Global
16
Exchange
3
SR, SM, Ex -231.40
-82.69
Matching
2-D Exchange
16
4
SR, SM, Ex -321.86
-90.46
Matching
Note: Models are shown in descending order of AIC values. ΔAIC calculations are
shown as the difference from the previously best fitting model. Bolded text indicates the
best overall fitting model.
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Table 3.2. Experiment 2 molecular models.
Model

Parameter
Count

Parameters

Signaled
AIC

Base

3

α,β,c

2246.41

Signaled
ΔAIC*

Unsignaled Unsignaled
AIC
ΔAIC*
2372.23
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Scaled Single-Learning
4
α,β,c,SM
1957.93 -288.48
1962.25
-408.98
Scaled Dual-Learning
5
αWin,αLoss,β,c,SM
1936.68
-21.25
1923.14
-39.11
(Outcome)
Scaled Dual-Learning
5
αA,αB,β,c,SM
1932.58
-4.1
1924.25
1.11
(Option)
Scaled Quad-Learning
7
αAWin,αALoss,αBWin,αBLoss,β,c,SM 1867.79
-64.79
1841.66
-82.59
(Option×Outcome)
Note: Models are shown in descending order of overall averaged AIC values. ΔAIC calculations are shown as the difference from the
previously best fitting model. Bolded text indicates the best overall fitting model.

Figure 3.1. Experiment 2 molar choice data. (a) Mean (± SEM) proportion of choices for
Option A as a function of Option A’s relative reward rates for the Signaled and
Unsignaled groups during the isomorphic food versus food procedure. Lines are the
NLME-determined best fit of Equation 14. (b-c) Mean (± SEM) proportion of choices for
Option A as a function of Option A’s relative reward rates and REMI dose for the
Signaled (b) and Unsignaled (c) group during the allomorphic drug vs. food procedure.
Lines are the NLME-determined best fit of Equation 16. Note: x-axes are logarithmic for
visualization.
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Figure 3.2. Experiment 2 molar parameters. Mean (± SEM) parameter estimates from the
NLME-determined best fit of Equation 16 to the molar choice data during the
allomorphic REMI vs. food procedure in Experiment 2. Abs = absolute value transform.
Note: error bars represent the between-subject variability of the predicted parameters.
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Figure 3.3. Experiment 2 interchoice intervals. (a) Mean (± SEM) interchoice intervals
for all trials in the Signaled and Unsignaled group as a function of dose. (b) Mean (±
SEM) interchoice intervals for trials following a rewarded choice for Option A (i.e., a
REMI-Win) in the Signaled and Unsignaled groups as a function of dose.
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Figure 3.4. Experiment 2 RL model fits. Example fits from the Scaled Quad-Learning
model to molecular choice data of Option A. Dashed vertical lines represent reward
magnitude changes for Option A in order of 3, 1, and 10 μg/kg doses. Panels show (a) an
Unsignaled rat one SD below, (b) a Signaled rat at, and (c) a Signaled rat one SD above
average the AIC. All data were smoothed with an 11-trial moving average.
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Figure 3.5. Experiment 2 molecular parameters. (a) Median parameter estimates from the
Scaled Quad-Learning model fit to the molecular choice data in Experiment 2. Medians
are shown due to the use of nonparametric test statistics, and error bars represent the
interquartile range. Note: β values are scaled according to the right y-axis. (b) Mean (±
SEM) predicted reward prediction errors (RPEs) from the Scaled Quad-Learning model
for Options A and B in the Signaled and Unsignaled group as a function of Option A’s
reward magnitude. The displayed RPEs are from equations 18-19 when VA and VB
equaled zero.
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CHAPTER 4
NEUROECONOMIC ASSESSMENT OF REWARD VALUE DURING
ALLOMORPHIC OPIOID VS. FOOD DECISION-MAKING
The results of Experiment 2 suggest that rats made allomorphic drug versus food
choices according to value-based decision-making mechanisms. As such, a logical
extension of Experiment 2 is to ask whether such allomorphic decisions are mediated by
the scaling of brain activity to the different dimensions modulating the propensity for
drug choices (e.g., Glimcher et al., 2005). As such, oxygen-sensitive electrodes were
implanted into the nucleus accumbens (NAc) of rats engaging in an allomorphic decisionmaking procedure as a proxy for fMRI BOLD signals (Francois et al., 2012; Lowry et al.,
2010). However, in order to maximize the ability to detect NAc O2 scaling with relative
reward rates, the signaling condition of Experiment 3 was changed to include distinct
win- and loss-associated stimuli for both options; this was done due to the finding of
improved sensitivity to relative reward rates in Experiment 2 for the Signaled group
during the isomorphic procedure. If NAc activity encodes a putative reward value signal,
then activity should scale with the modulators of drug choice such as relative reward rates
and magnitudes.

Experiment 3
Methods
Subjects
Six adult male Sprague-Dawley Rats (Harlan Inc; Indianapolis, IN, USA) were
used in the experiment. Rats were individually housed on a 12:12 hour light:dark cycle
(lights on at 7:00 a.m.) and had free access to water but were food restricted to 15 g of
standard lab chow per day (Harlan Inc.) post session. All research was approved by the
University of Kentucky Institutional Animal Care and Use Committee (Protocol # 20110885).
Apparatus
The apparatus was the same as in Experiment 2.
70

Drugs

Remifentanil hydrochloride gifted from the National Institute on Drug Abuse

(Bethesda, MD, USA) was mixed in sterile saline (0.9% NaCl).
Oxygen biosensor
Microelectrode arrays (MEAs, S2 configuration; CenMeT, Univeristy of
Kentucky) were built as previously described (Rutherford, Pomerleau, Huettl, Strömberg,
& Gerhardt, 2007) and consisted of four platinum recording sites (15 μm × 333 μm)
arranged in dual pairs. Once built, the MEAs were calibrated in vitro at 100 Hz using the
FAST16 mkIII electrochemical recording system (Fast Analytical Sensing Technology,
Quanteon, LLC, Nicholasville, KY). In vitro calibration was adapted from Ledo et al.
(2017). Briefly, a 20 mL solution of 0.05 M, pH 7.4, phosphate-buffered saline was
purged of O2 with nitrogen at 37°C. Three additions of 4.95 μM oxygen were then used
to generate a calibration curve to determine MEA sensitivity (slope, nA/μM), limit of
detection (in μM, signal-to-noise = 3), and linearity (R2 ≥ 0.9).
Establishing operations
All establishing operations were the same as Experiment 1.
Isomorphic food versus food choice
Rats were trained on the same isomorphic decision-making procedure as
Experiment 1 with the exception that all rats were in a Double Signaled condition.
Illustrated in Figure 4.1, Option A was equivalent to Option A for the Signaled groups in
Experiments 1 and 2. However, here, choosing Option B produced a lever stimulus when
a reward followed and a jewel light stimulus directly above the lever when a loss
occurred for 10 s. Thus, there was no differential signaling across Option A and B. In
order to reach a stable baseline, a training criterion was set such that subjects had to have
SR values greater than or equal to -0.25 to show comparable values with Experiments 1
and 2. However, equipment for subsequent training was not always available once
training criterion was reached and resulted in less systematic training times. The average
training time contingent on both SR values and equipment availability was 54 sessions
(SEM = 11.29).
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Catheter surgery
Once the training criterion had been met, rats underwent surgery for implantation
of the jugular catheter as described in Experiment 2.
Drug self-administration training
Drug self-administration training was as described in Experiment 2 with the
exception that all rats were only trained on the 10 μg/kg REMI dose. Following choice of
the drug-associated Option A, the infusion began 4.1 s into the 10-s terminal link interval
and finished concurrent with terminal link offset.
Food versus drug training
Following completion of drug self-administration training, all rats completed food
versus drug training as described in Experiment 2.
Preliminary allomorphic decision-making procedure
After food versus drug training, all rats completed approximately five days of
training on the allomorphic decision-making procedure described in Experiment 2.
Experiment 3 also included forced-choice trials, which were identical to free-choice trials
except that, after orienting to the house-light, only one of the two nosepokes were
available. Forced-choice trials were implemented in order to maintain adequate sampling
of both choice options across all conditions of training and because previous research has
shown dissociable effects between forced- and free-choice trials (e.g., Sugam, Day,
Wightman, & Carelli, 2012). There were 12 forced choice trials per block (6 per option)
for a total of 48, which reduced the total free-choice trial count (when both choice options
were available) to 72 total trials.
Electrode implantation
Following completion of preliminary allomorphic decision-making training, rats
underwent a second surgery for the implantation of the O2-sensitive MEA. Prior to
surgery, all rats were given a 10 mg/kg dose of carpofen (Rimadyl, Pfizer, NYC) and 1
mL of 0.9% sterile saline subcutaneously. Rats were then anesthetized using 4%
isoflurane (Isothesia, Henry Schein, Melville, NY), their head was shaved, and the rat
was placed in a stereotaxic frame (David Kopf Instruments, Tujunga, CA) on top of a
circulating water bath to maintain body temperature at 37°C. Rats were maintained at an
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isoflurane level of 1-3%, artificial tears (Henry Shcein, Melville, NY) were applied to the
rats’ eyes, and the shaved heads were disinfected with Hibiclens scrub (Mölnlycke Health
Care, Norcross, GA) and 70% ethanol. An incision was made on the rat’s head to expose
the skull, followed by a craniotomy exposing the right hemisphere of the NAc (AP: +1.82.04; ML: ± 1.5; DV: -7.0 relative to bregma; Paxinos & Watson, 2006). Three screws
(Amazon supply, part No. B00FN0K02) were then screwed into the skull and a small
burr hole was made contralateral to the site of the craniotomy for implantation of the
Ag/AgCl reference electrode. The MEA was then implanted into the NAc, the Ag/AgCl
reference electrode into the burr hole, and the MEA was set in place using dental acrylic
(Ortho Jet Powder and Jet Acrylic Liquid, Lang Dental Manufacturing Co., Wheeling
IL). Rats were allowed to recover for three days prior to resuming behavioral training and
were given repeated carpofen (10 mg/kg s.c.) daily.
Electrochemical recordings
Oxygen measurements were performed with the FAST-16 mkIII recording system
using a low noise 4-channel Rat Hat amplifier system (Quanteon, LLC, Nicholasville,
KY) connected through a low-noise commutator (Plastics One, Inc., Roanoke, VA) at
100 Hz. During behavioral training, the MEA was maintained at -0.6 V versus the
Ag/AgCl reference electrode (Ledo et al., 2017).
Reestablishing operations
Following electrode implantation, rats again underwent drug self-administration
training followed by drug versus food training as described above.
Allomorphic decision-making procedure
After reestablishing procedures, rats returned to the allomorphic decision-making
procedure as previously described. All rats were trained for a minimum of 10 sessions
per REMI dose, first with Option A providing 10 μg/kg of REMI, then 3 μg/kg, and
finally 1 μg/kg. For the first five days of each dose, voltage was not applied to the
electrode and no electrochemical recordings were collected. For the remainder of training
at each component, voltage was applied to the MEA and recordings collected. A
minimum of five recording sessions were collected for each animal but sessions could be
excluded due to problems with the delivery of REMI, poor quality of the electrical
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recordings, or failure to complete the session. In the case of excluded sessions, further
training was necessitated. After all data were collected, animals were euthanized, the
brains were extracted and flash frozen, and 40 μm brain slices were prepared using a
cryostat. The slices were stained using Cresyl Violet (Sigma-Aldrich, St. Louis, MO) and
visualized to confirm MEA placements into the NAc (Figure 4.15).
Data Analysis
Molar analysis
Molar data analysis closely followed Experiment 2. Choice data were expressed
as the proportion of choices for Option A as a function of Option A’s relative reward
rates. To quantify the initial isomorphic food versus food data, a NLME model taking the
form of Equation 14 was used in the NLME package in R. To quantify the allomorphic
drug versus food data, a NLME model taking the form of the Global Exchange 2-D
Matching Equation (Equation 16) was used. No model comparisons were conducted due
to the absence of groups. All molar choice data reflect the average of five sessions, and
no forced choice trials were included in molar choice data analysis. The same sessions
used for the molar choice data analysis were used to analyze ICIs in the same manner as
Experiment 2, except there was no Group factor in the LME model.
Molecular analysis
Molecular analysis was the same as Experiment 2 except no group comparisons
were conducted on the parameter estimations. Additionally, on forced choice trials, the
value of both options was updated but no choice was predicted. Instead, the last predicted
choice was retained for the forced choice trial and did not count towards log-likelihood
estimations (Marshall & Kirkpatrick, 2017). Analysis of RL parameters was only
conducted if the best fitting model included more than one α parameter; in this case, a
series of pairwise Wilcoxon signed-rank tests were run with Hochberg corrections that
included the relevant factors of Option, Outcome, and their interaction. Finally, RPEs for
both options were calculated as a visual aid to illustrate the differences in model value
updating.
Oxygen analysis
Changes in oxygen dynamics were analyzed for each trial by first creating a 40-s
trial window around the time of a choice. The trial window was then segmented into three
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separate intervals: baseline, cue, and reward. Baseline intervals were defined as 4 s prior
to a choice until 1 s prior to a choice (3 s total). Cue intervals were defined from the time
a choice was made until the end of the 10-s terminal link stimulus (10 s total). Reward
intervals were defined as 1.5 s prior to the offset of the terminal link stimulus (in order to
capture large, convoluted signals between cue and reward intervals) until 5 s past the ITI
(27.5 s total). However, in the case that the next trial was initiated prior to the end of the
reward interval, the reward interval was truncated to 3 s before the initiation of the next
trial (i.e., orienting response). All trial windows were smoothed with a 0.25 s moving
average.
Trial windows were then analyzed using the findpeaks function in MATLAB,
which identifies local maxima (i.e., peaks) in timeseries data separately for the cue and
reward intervals. All local maxima were required to have a minimum duration of 0.75 s,
and the largest returned value was recorded as the peak for a given trial’s cue or reward
interval. Furthermore, given that RPEs can be both positive and negative (e.g., Schultz,
2010), each trial window was analyzed again to search for local minimums (i.e., troughs)
by multiplying the trial window by -1. However, early in the analysis it became apparent
that REMI-Wins in the 10 μg/kg condition produced a very large O2 response that
extended well beyond the reward interval previously described. As such, reward intervals
for REMI-Wins in the 10 μg/kg condition were set to 190 s from the time of choice.
Additionally, to aid the findpeaks function in capturing the response to REMI 10 μg/kg
infusions, the trial window was filtered with an elliptic lowpass filter using the ellip
function in MATLAB. The lowpass filter stopband was set to 0.09 Hz and was chosen
through experimentation with exemplar trials due to its minimal alteration of the overall
signal. In the case that the next trial was initiated prior to the end of the 190-s reward
interval, the reward interval was truncated to 3 s prior to the trial’s initiation.
The dependent variables collected from each cue and reward interval of a given
trial were the largest-amplitude peak and trough (i.e., maximum and minimum,
respectively), expressed as a percent change from the mean of the baseline interval, the
width of the largest-amplitude peak and trough, and the proportion of trials in which a
peak or trough was found. The dependent variables were then entered into a linear mixedeffects (LME) model in MATLAB with Subject as a nominal random factor, Dose as a
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continuous fixed factor, Block (i.e., relative reward rates) as a continuous fixed factor,
Option as a nominal fixed factor, Trial Type (free vs. forced) as a nominal fixed factor,
and Outcome as a nominal fixed factor. All nominal variables were effects coded and
continuous variables mean centered. The primary interest of the current study was how
any changes in the O2 signal scaled with either relative reward rates (i.e., Block) or dose
manipulations of REMI. In the case of significant effects coupled with significant
interactions, the highest order interaction was interpreted. For post hoc tests of
interactions, coefficient tests were run using the coeftest function in MATLAB. Finally,
in the case of apparent quadratic trends, quadratic trend analyses were conducted in JMP.
To differentiate the two sets of analyses, reporting the post hoc testing in MATLAB
herein involves the term slope for the testing of linear simple slopes, while those done in
JMP herein involves the term dose and dose2.
Important limitations with the MEA data collected warrant discussion. For
instance, two out of six animals displayed repeated saturation of the MEA signal that
precluded collection during select time periods, one animal displayed behavioral
stereotypy during win trials that produced electrical disturbances, and one MEA changed
its resting baseline values within session. For these reasons, the entire electrical signal for
each session was first visualized prior to analysis. Upon detecting nonfaradaic current,
any trials where the aforementioned electrical disturbances existed were manually
excluded. The average percent of trials excluded across subjects was 13.21% (SEM =
5.12%).
Results
Molar analysis
Figure 4.2a shows the proportion of choices for Option A as a function of Option
A’s relative reward rates during the isomorphic food versus food procedure. Similar to
previous experiments, the rats tended to favor the options with greater relative reward
rates. Analysis with the general matching NLME model also confirmed the rats’ choices
were sensitive to the changing relative reward rates [SR = 0.45, F(1, 17) = 106.08, p <
.001]. Overall, choices of Option A decreased concurrent with decreases in its relative
reward rates, with effectively no bias for either alternative [b = 0.99].
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Figure 4.2b shows the proportion of choices for Option A as a function of Option
A’s relative reward rates during the allomorphic drug versus food procedure. Drug
preferences were again under apparent control of both relative reward rates and dose, but
the sensitivity to rewards rates appeared less pronounced. Results derived from the 2-D
Global Exchange Matching equation confirmed the apparent trends. There was
significant sensitivity to changes in relative reward rates [SR = 0.26, F(1, 64) = 18.95, p <
.001] and relative reward magnitude, [SM = 2.6, F(1, 64) = 251.85, p < .001], and the
reward magnitude for Option equated to ~2 μg/kg dose of REMI [Ex = 2.06]. Finally,
Figure 4.3 shows the average ICIs as a function of dose for all trials as well as only the
trials following REMI-Wins. Although the function showed an apparent quadratic trend,
a quadratic effect of dose was not significant. ICIs significantly increased as a function of
dose [F(1, 5) = 11.4, p = .02], ICIs following REMI-Wins were longer overall [F(1, 5) =
18.34, p = .008], and ICIs increased as a function of dose more rapidly following REMIWins than the average of all trials [F(1, 5) = 37.43, p = .002].
Molecular analysis
Similar to previous experiments, the Scaled Single-Learning model tested if
altering the Base RL model’s valuation equations with the exchange-rate (Ex) and
sensitivity to magnitude parameters (SM) would improve overall model fits. Indeed,
inclusion of the Ex and SM parameters resulted in overwhelming evidence in favor of
relative magnitude scaling (see Table 4.1). However, unlike previous experiments,
including additional α parameters in subsequent models did not result in overall
improvements in model fits. According to each model’s AIC value, the Scaled SingleLearning model was the best fitting model. But, upon assessing model fits it became
apparent that the Scaled Single-Learning model was over fitting the 10 μg/kg and 3 μg/kg
dose conditions and underfitting the 1 μg/kg condition. To assess whether the Scaled
Single-Learning model was indeed underfitting the 1 μg/kg condition, each subject’s
average residual for the three dose conditions were plotted and compared to the next best
fitting Scaled Quad-Learning model. Shown in Figure 4.4, the average residuals showed
an apparent increase in the 1 μg/kg condition in four out of six subjects that was not
present in the Scaled Quad-Learning; for this reason, despite the Scaled Single-Learning
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model having the lower AIC, the Scaled Quad-Learning model was selected as the bestfitting model.
Figure 4.5 shows three example model fits that approximate the average AIC (±
one standard deviation). Overall, the RL model tended to capture the choice dynamics of
the current experiment less well than previous experiments, but still followed the general
trends of the data [ΔAIC = -1190.50 relative to the chance model]. Parameters for the
Scaled Quad-Learning model are shown in Figure 4.6a and are overall comparable with
those from Experiment 2. However, no α values were significantly different after
correcting for multiple comparisons. Finally, the calculated RPEs are illustrated in Figure
4.6b and showed the ordinally expected patterns of Option A providing greater value
updating on wins than Option B as a function of dose.
Oxygen
Figures 4.7 and 4.8 show averaged oxygen traces across all animals for the most
common result across measures: Dose × Option × Outcome. The average traces were
concordant with ordinal predictions of RPEs. Namely, peaks tended to occur at the
presentation of the win- and loss-associated stimuli while, during the reward interval,
secondary or large convoluted peaks and troughs occurred for wins and losses,
respectively.
For the analysis of average peaks and troughs, there were no systematic effects on
troughs during the cue interval related to either Block or Dose. The proportion of trials
that showed a trough during the cue interval were relatively low compared to other
measures discussed below (Mean = 0.61, SEM = 0.01) and, as suggested by the average
traces (Figures 4.7-4.8), cue intervals were primarily associated with peaks rather than
troughs. Additionally, systematic scaling to relative reward rates was also not apparent in
the current dataset. Shown in Figure 4.9, cue and reward interval peaks appeared to be
trending as a function of relative reward rates when collapsing across all other variables,
but changes in O2 did not systematically scale with Block on any measure.
Oxygen peaks to the reward-associated cues were present on nearly all trials
[Mean = 0.95, SEM < .01], and percent amplitude changes showed significant effects of
Dose [F(1, 511) = 3.94, p = .048] and Outcome [F(1, 511) = 6.13, p = .014] and a
significant Dose × Option interaction [F(1, 511) = 4.31, p = .038]. Shown in Figure
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4.10a, the interaction had apparent quadratic trends in opposing directions for REMI and
food, which were probed by assessing the significance of a quadratic fit. Indeed, both
quadratic terms for REMI [dose = 0.10, p = .333; dose2 = -0.07; p = .048] and food [dose
= -0.33, p < .001; dose2 = 0.07; p = .023] were significant but in opposite direction.
Percent amplitude change to signals associated with food significantly decreased as a
function of dose in a nonlinear fashion, while the percent amplitude changes to signals
associated with REMI initially increased and then decreased as a function of dose.
Additionally, the main effect of Outcome (Figure 4.9b) was due to peak amplitude
changes being higher overall for cues signaling a win than those signaling a loss. Cue
widths showed a significant effect of Dose [F(1, 511) = 9.71, p = .002] and significant
Dose × Outcome [F(1, 511) = 10.92, p = .001] and Dose × Option × Outcome
interactions [F(1, 511) = 9.29, p = .002]. Illustrated in Figure 4.10c, the interaction was
driven by the average width of peaks to REMI-Win-associated cues significantly
decreasing as a function of dose [slope = -0.07, p < .001], while the widths associated
with REMI-Loss cues showed a non-monotonic increase and then decrease [dose = .06, p
= .030; dose2 = -0.02, p = .046].
O2 peaks [Mean = 0.77, SEM = 0.01] and troughs [Mean = 0.92, SEM = 0.01]
during the reward interval were also prevalent across trial types. The percent amplitude
changes for O2 peaks during the reward interval showed significant effects of Option
[F(1, 502) = 8.90, p = .003] and Outcome [F(1, 502) = 12.79, p < .001] and significant
Dose × Option [F(1, 502) = 15.99, p < .001], Option × Outcome [F(1, 502) = 26.67, p <
.001], and Dose × Option × Outcome interactions [F(1, 502) = 26.90, p < .001]. Shown in
Figure 4.11a, the three-way interaction was driven by Remi-Win peaks significantly
increasing as a function of dose [slope = 0.83, p < .001] while no other trial outcomes
showed slopes significantly different from zero. Reward-interval peak widths also
corroborated the effects of amplitude. Reward-interval peak widths showed significant
effects of Dose [F(1, 502) = 18.59, p < .001], Option, [F(1, 502) = 4.79, p = .030],
Outcome [F(1, 502) = 4.07, p = .044], and significant Dose × Option [F(1, 502) = 176.07,
p < .001], Option × Outcome [F(1, 502) = 15.77, p < .001], and Dose × Option ×
Outcome interactions [F(1, 502) = 165.94, p < .001]. The three-way interaction was
driven by peak widths positively increasing as a function of dose [slope = 2.37, p < .001]
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while no other trial outcomes showed slopes significantly different from zero (Figure
4.11b). Reward interval widths as a function of dose during REMI-Wins also showed a
significant quadratic trend [dose = 1.66, p < .001, dose2 = 0.32, p = .003], indicating
widths increased nonlinearly as a function of dose.
The percent amplitude changes for O2 troughs during the reward interval showed
significant interactions of Dose × Option [F(1, 289) = 26.82, p < .001] and Dose ×
Outcome [F(1, 289) = 7.68, p = .006]. Both interactions showed apparent quadratic
effects as a function of dose (Figure 4.12a-b). For the Dose × Option interaction, the
amplitude of troughs for choices of food rewards became less negative at 3 μg/kg and
then appeared to level off at 10 μg/kg [dose = 0.18, p = .032; dose2 = -0.07, p = .032],
while troughs associated with REMI choices became initially less negative at 3 μg/kg and
then more negative at 10 μg/kg [dose = -0.53, p < .001]. For the Dose × Outcome
interaction, troughs associated with losses became less negative at 3 μg/kg and then
leveled off at 10 μg/kg [dose = 0.16, p = .050; dose2 = -0.07, p = .016], while troughs
associated with wins were less negative at 3 μg/kg and then more negative at 10 μg/kg
[dose = -0.26, p = .130; dose2 = -0.14, p = .021]. The widths of the reward-interval
troughs showed significant effects of Dose [F(1, 289) = 9.98, p = .002] and Option [F(1,
289) = 13.79, p < .001] and significant Dose × Option [F(1, 289) = 20.53, p < .001], Dose
× Outcome [F(1, 289) = 31.14, p < .001], and Dose × Option × Outcome interactions
[F(1, 289) = 10.61, p = .001]. The three-way interaction was driven by the trough widths
for REMI-Wins significantly increasing as a function of dose [slope = 1.11, p < .001],
while no other conditions had slopes significantly different from zero (Figure 4.12c).
Oxygen-behavior relationships
A final set of analyses was run to assess how O2 scaling to REMI doses related to
behavioral choices scaling with REMI doses in the matching and RL models. For molar
data, the ratio of peak O2 (REMI / Food) during the reward interval was compared to the
estimated reward magnitude of REMI (i.e., Remi / Ex) for all subjects; however, this
analysis (see Figure 4.13) did not reach significance [r = 0.46, p = .053]. For molecular
data, RPEs for all subjects on win trials were correlated with the percent amplitude O2
change during the reward interval. RPEs and percent O2 change were significantly
correlated [r = 0.24, p < .001], although considerable variability was present. Finally, the
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relative reward magnitude terms in the Scaled Quad-Learning RL model (i.e., λA / λB),
previously expressed as the REMI dose divided by the exchange rate parameter, was
replaced with the ratio of average peak O2 (REMI / Food) obtained during the reward
interval and refit to the behavioral data. Substituting peak O2 for the behaviorally derived
reward magnitude values revealed that the RL model could still successfully parameterize
trial-by-trial choices. Additionally, the average AIC of the model (AIC = 842.40) was
comparable to the other models fit with the behaviorally derived reward magnitude
values and suggests feasibility in peak O2 as scaling with relative reward magnitude
similar to behavioral choices.
Discussion
The purpose of the current experiment was to determine if changes in NAc O2
activity during the allomorphic drug versus food procedure would scale with behavioral
determinants of REMI’s relative reward value. Similar to Experiment 2, rats’ propensities
to choose REMI was shown to be modulated by both the relative reward rates and
magnitudes of the concurrently offered commodities. Changes in NAc O2 activity also
showed some evidence of REMI and food being scaled on a common physiological
utility signal, as the appearance of reward-associated cues or reward delivery tended to
result in qualitatively similar peaks of NAc O2 activity. The present experiment is
believed the first to show that decisions for REMI or food produce comparable effects on
NAc O2 activity. Additionally, the data suggested that NAc O2 activity scaled with the
relative reward magnitude of the reward-associated cues, while NAc O2 activity during
the reward interval appeared to scale with the magnitude of REMI dose. However, NAc
O2 activity did not scale with relative reward rates.
With respect to behavior, the signaling condition of the current experiment was
notably different than Experiment 2 in that both REMI and food choices resulted in
spatially distinct win- and loss-paired cues; this was done in an attempt to achieve greater
behavioral sensitivity to relative reward rates that might then increase the likelihood of
observing NAc O2 scaling. During the initial isomorphic training, the inclusion of
outcome-dependent cues for food reward did indeed produce a qualitative increase in
sensitivity to relative reward rates (SR = 0.45) over Experiments 1 and 2 (avg SR = 0.30
and 0.35, respectively). Furthermore, signaling both choice alternatives effectively
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removed bias to either option. Thus, prior to exposing the rats to allomorphic drug versus
food choice conditions, the rats’ choices as a function of reward probability were
relatively sensitive compared to previous conditions and showed very little bias for either
alternative.
During the allomorphic drug vs. food procedure, the rats replicated the results of
Experiment 2 by showing significant sensitivities to relative reward rates and
magnitudes; these results suggest that rats making choices between REMI and food were
doing so in a value-based manner. Additionally, ICIs showed a similar increase as a
function of dose to those of Experiment 2 as well as another report assessing cocaine
choices (Beckmann et al., 2019). However, while sensitivities to relative reward rates
were significant, the qualitatively increased sensitivities seen in the isomorphic procedure
returned to a comparable level as Experiment 2 during allomorphic choice. The exact
reason for the decrease between conditions is unclear. One possibility could be that
training rats on a descending order of REMI doses resulted in an increased REMI bias.
For instance, the exchange-rate parameter (Ex = 2.06) for the present experiment was
qualitatively lower than that of both groups in Experiment 2 (Ex = 3.16 and 5.86).
Alternatively, it could be that the inclusion of forced-choice trials sufficiently changed
the decision-making context, such that forcing rats to choose a less preferred alternative
resulted in more absolute preferences. It is also interesting that there were no O2
differences between trials of free versus forced choices, as previous work has found using
voltammetry (e.g., Sugam et al., 2012). In either case, the overall results of the current
experiment’s molar analyses replicate the findings from Experiment 2 showing evidence
of value-based decision-making for drug reward as well as independent effects of relative
reward rates and magnitude predicted by matching equations (Rachlin, 1971).
Also similar to Experiment 2, RL models (Table 4.1) were successfully able to
parameterize rats’ allomorphic choices. Altering the valuation equations to account for
relative reward magnitude scaling in the Scaled Single-Learning model again resulted in
substantial improvements relative to the base RL model. Thus, for the third time, relative
magnitude scaling is supported in the RL models. Additionally, the parameter estimates
for the current experiment corroborated those from Experiment 2 with the exception of
the perseveration parameter (c) being negative for the first time; this suggests that rats
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had a tendency to alternate from their previous choice independently of the reward value
between options, which may have been impacted by the inclusion of forced choice trials
forcing rats to alternate.
For the O2 signals, the overall results suggest that NAc activity scaled with reward
magnitude for REMI infusions and possibly relative reward magnitude for the rewardassociated cues. For instance, peak O2 changes to the food-associated cues showed a
nonlinear decrease as a function of dose that could be interpreted as scaling with food’s
relative reward magnitude. That is, food reward had the greatest preference at the 1 μg
dose and then food preferences decreased as dose increased, similar to O2 peak changes.
Furthermore, given that the reward-associated cues were perfectly correlated with trial
outcome, the ordinal predictions of the RPE hypothesis would suggest that the cues
should produce signal changes associated with the reward magnitude of the outcome
(Abler et al., 2006; Fiorillo et al., 2003; Schultz, 2010) as opposed to the probability of
reward.
Alternatively, O2 activity to REMI-associated cues showed a quadratic function
not unlike that of a dose-response curve. One possible interpretation is that, similar to
single-schedule measures of reward value, O2 changes to REMI cues represent an
interaction of value-based mechanisms and effects associated with REMI. For the 1 and 3
μg/kg conditions, a linear increase in NAc O2 responses suggests possible scaling of the
forthcoming REMI reward magnitude. However, at the 10 μg/kg condition, biological
compensatory mechanisms may have overcome the otherwise value-based signal
changes. Indeed, drug-associated cues have been shown able to produce both withdrawal
symptoms and alter an individual’s tolerance to drug effects, as though the body is
“preparing” for drug (Siegel, 2005). Given the relatively large effect administration of the
10 μg/kg dose had on O2 activity (discussed below), it seems likely that compensatory
effects may also have been present. The interpretation that O2 peaks to reward-associated
cues scale with reward magnitude would also be consistent with work showing that
individuals who are experienced with a particular drug show increased reactivity to drugassociated cues compared to inexperienced controls (e.g., David et al., 2005; Li et al.,
2012). However, the interpretation is complicated in that Figure 4.10a represents O2
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responses to both REMI-Wins and REMI-Losses, making a compensatory mechanism
interpretation somewhat speculative.
Win-paired cues across both options also had significantly higher peak O2
changes. RPE hypotheses do not make specific predictions regarding win versus loss
trials, but wins resulting in higher O2 amplitude changes may reflect general excitation,
which has been shown previously (e.g., Sugam et al., 2012). Finally, the widths of peak
O2 changes to reward-associated cues showed an interaction, in which REMI-Wins
displayed dose-dependent decreases in widths while losses displayed an overall increase.
An a priori reason for the dose effects on widths is not clear, but compensatory
mechanisms may also be involved that resulted in a dissociation between REMI-Wins
and losses.
Changes in O2 activity during the reward interval showed large dose-dependent
effects for REMI while those for food rewards were dose independent. For O2 peaks,
NAc activity for REMI-Wins during the reward interval dose-dependently increased
along with increases in peak widths, but there were no changes for food delivery. These
results suggest that O2 peaks during the reward interval scaled with reward magnitude but
in a nonrelative manner. That changes in NAc activity, or the broader ventral striatum
area, scaled with reward magnitude manipulations corroborates (1) a large body of fMRI
work (Daniel & Pollmann, 2014; Levy & Glimcher, 2012) using primarily monetary
rewards, (2) electrophysiological recordings in the striatum of nonhuman primates
responding for food or liquid rewards (Schultz, 2010), and (3) electrophysiological and
fast-scan voltammetry recordings in the NAc of rats responding for food (e.g., Goldstein
et al., 2012; Saddoris et al., 2015b). Additionally, that NAc O2 responded in a
qualitatively similar way for food and REMI rewards adds to the growing list of different
reward types that the brain responds to in a similar, value-suggestive manner (Levy &
Glimcher, 2012) and corroborates fast-scan voltammetry work in rats responding for
cocaine (e.g., Cameron et al., 2014). However, previous work assessing brain activity
relative to a commodity’s reward value often do so under isomorphic conditions and, if
reward magnitude is manipulated, only show the results for the commodity whose
magnitude increases (e.g., Abler et al., 2006; Knutson et al., 2005). For example, the
reward magnitude of food was not manipulated in the present experiment and, as such,
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many studies may not have shown the activity changes in food as a function of dose;
however, such changes are potentially important in determining whether brain region
activity is scaling reward magnitude in a relative or independent manner. Further research
is therefore necessary to corroborate the potential scaling of reward-associated cues to
relative reward magnitude seen here.
Trials associated with REMI, as well as wins, also separately engendered
differential O2 trough activity. Although the three-way interaction between Option,
Outcome, and Dose was not significant, O2 trough activity was likely driven by the 10-μg
REMI-Wins producing large troughs (Figure 4.7a) that is further substantiated by the
significant three-way interaction for trough widths (Figure 4.12c). These troughs suggest
a temporary depletion of local O2 that then rebounded, which is consistent with rodent
fMRI work that administered both REMI and morphine (Liu, Greve, Dai, Marota, &
Mandeville, 2007). Furthermore, given the density of ventral striatal GABAergic medium
spiny neurons that often express mu opioid receptors (Salgado & Kaplitt, 2015; Scofield
et al., 2016), the 10 ug-associated troughs likely stemmed from inhibiting GABA
interneurons that led to disinhibition of the NAc generally (Liu et al., 2007). While these
effects of O2 troughs likely stemmed from the direct pharmacology of REMI, they were
not commensurate with RPE hypotheses. That is, reward omission should be associated
with either an increased proportion or amplitude change in decreased regional activity,
yet neither effect was present in the current study. However, hypotheses surrounding
decreases in activity have generally been less robust and consistent (Schultz, 2010;
Yacubian et al., 2006), and some would likely argue that pharmacological agents are not
fair tests of RPE hypothesis. Thus, the present O2 trough results do not present existential
threats to RPE hypotheses. But, if the RPE signal ostensibly represents a common neural
signal for all reward value, then all reinforcing outcomes of behavior are candidate to that
pathway. It is therefore important to test the boundary conditions of our hypotheses to
ensure studies do not simply repeat the same tests using small variants.
Changes in NAc activity were also assessed in relation to the observed changes in
behavior at the molar and molecular level. For the molar data, the ratio of peak O2 for
REMI and food during the reward intervals were correlated with the modeled REMI and
food reward magnitude ratios; this analysis showed that relative O2 tended to covary with
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the molar estimates of relative reward magnitude, but did not reach significance. For the
molecular data, RL-modeled RPEs were significantly associated with peak O2 changes as
shown previously with fMRI in humans (Gläscher et al., 2010) and fast-scan voltammetry
in rats (Hart et al., 2014). Additionally, replacing the reward-magnitude terms for REMI
and food in the Scaled Quad-Learning RL model with relative peak O2 ratios resulted in
the RL model still able to parameterize trial-by-trial choices. Although there was
considerable variability in the present measures, the correlation between peak O2 and
RPEs suggests that value updating for qualitatively different commodities (i.e., food and
REMI) happens in a similar RPE-like manner within the NAc. Furthermore, while the
present study found no effects of O2 scaling with scheduled relative reward rates, the
correlations between RPEs and peak O2 changes do suggest O2 activity was varying as a
function of local rates of reward probability. Future research may therefore benefit by
having increased statistical power to more effectively detect systemic effects of brain
activity as a function of scheduled relative reward rates.
One possible source of the high variability in the O2-behavior correlations may
involve the use of a drug that is capable of producing direct pharmacological effects other
than just the effects of reward value in the NAc. Although previous research has shown
that brain measures in the striatum and prefrontal cortex for cocaine and heroin are
related to behavior (e.g., Cameron et al., 2014; Guillem et al., 2018; Lenoir et al., 2007;
Saddoris et al., 2016), these studies used different recording techniques and only
measured one dose level relative to food without attempting to scale changes in reward
magnitude with changes in brain measures. Given the ubiquity of ostensible prediction
error signals found in the brain (Levy & Glimcher, 2012), future studies should scale
brain and behavior changes in more dynamic procedures such as that here, which is more
commonly done in the human and nonhuman primate literature.
Another possible source of variance in the present experiment may have been that
the rats were freely moving (Wallis, 2012). For instance, one human fMRI study had
participants either respond to a button or use eye-movement saccades to select choices
and found the magnitude of the underlying neurocircuitry results were significantly
different. (Wunderlich, Rangel, & O'Doherty, 2009). However, for rodents to engage in
autonomous decision-making, there is little choice but to allow for freedom of movement.
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Future research should therefore take the response-modality of how choices are
physically made into account.
Overall, the present experiment revealed several novel findings relevant to our
understanding of decision making. As in Experiment 2, rats were shown to choose as if
their decisions were value-based for allomorphic choices between food rewards and
REMI rewards of varying doses. Also, oxygen within the NAc was shown to respond in a
way commensurate with RPE hypotheses for both food and REMI reward in freelymoving rats. Peak O2 responses to REMI infusions were also shown to be dose-dependent
and were commensurate with reward magnitude scaling. Finally, RL-modeled RPEs were
shown to correlate with the peak-O2 changes for both REMI and food rewards. The
results therefore suggest that drugs may be valued on a common scale as nondrug reward,
but further research is needed. Additionally, the present experiment serves as an example
of how future research can increase procedural homology between preclinical studies
using electrodes and human fMRI studies. Although specificity of the signal is lost as a
trade-off, ever-advancing preclinical manipulations to target specific cell types such as
designer drugs and receptors (Urban & Roth, 2015) or optogenetics (Fenno, Yizhar, &
Deisseroth, 2011) could be coupled with future research to regain manipulative control of
specific mechanisms of interest.
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Table 4.1. Experiment 3 molecular models.
Model

Parameter
Count

Parameters

AIC

ΔAIC

Base
3
α,β,c
1510.60
Scaled Dual-Learning
5
αWin,αLoss,β,c,SM
864.91
-645.69
(Outcome)
Scaled Dual-Learning
5
αA,αB,β,c,SM
853.96
-10.95
(Option)
Scaled Quad-Learning
7
αAWin,αALoss,αBWin,αBLoss,β,c,SM
809.51
-44.45
(Option×Outcome)
Scaled Single-Learning
4
α,β,c,SM
784.44
-25.07
Note: Models are shown in descending order of AIC values. ΔAIC calculations are shown as the difference from the previously best
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fitting model. Bolded text indicates the chosen model.

Figure 4.1. Experiment 3 general methods. (a) Sequence of events during the behavioral
procedures on free-choice trials in Experiment 3. The reward for both options on win
trials during the isomorphic procedure was one food pellet. The reward for Option A
during the allomorphic procedure was an infusion of REMI (10, 3, or 1 μg/kg) and one
food pellet for Option B. * indicates that all stimuli offset following the event. (b) Table
outlining the probabilities of events and the relative reward rates for Options A and B.
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Figure 4.2. Experiment 3 molar choice data. (a) Mean (± SEM) proportion of choices for
Option A as a function of Option A’s relative reward rates during the isomorphic food
versus food procedure. Lines are the NLME-determined best fit of Equation 14. (b) Mean
(± SEM) proportion of choices for Option A as a function of Option A’s relative reward
rates and REMI dose during the allomorphic drug versus food procedure. Lines are the
NLME-determined best fit of Equation 16. Note: x-axes are logarithmic for visualization.
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Figure 4.3. Experiment 3 interchoice intervals. Mean (± SEM) interchoice intervals for
all trials (All) or only trials following rewarded choices for Option A (i.e., REMI-Wins;
Drug) as a function of dose in Experiment 3.
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Figure 4.4. Experiment 3 RL residuals. Average RL residuals for the Scaled SingleLearning and Scaled Quad-Learning models as a function of dose. Data points represent
the average of one individual. Horizontal lines indicate the average across individuals.
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Figure 4.5. Experiment 3 RL model fits. Example fits from the Scaled Quad-Learning
model to molecular choice data of Option A. Dashed vertical lines represent reward
magnitude changes for Option A in order of 10, 3, and 1 μg/kg doses from left to right.
Panels show (a) a rat one SD below, (b) a rat at, and (c) a rat one SD above average the
AIC. All data were smoothed with an 11-trial moving average.
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Figure 4.6. Experiment 3 molecular parameters. (a) Median parameter estimates from the
Scaled Quad-Learning model fit to the molecular choice data in Experiment 3. Medians
are shown due to the use of nonparametric test statistics and error bars represent the
interquartile range. Note: β values are scaled according to the right y-axis. (b) Mean (±
SEM) predicted reward prediction errors (RPEs) from the Scaled Quad-Learning model
for Options A and B as a function of the reward magnitude for Option A. The displayed
RPEs are from equations 18-19 when VA and VB equaled zero.
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Figure 4.7. Example O2 traces for REMI. Average O2 traces for Option A (REMI)
collapsing over relative reward rates and rats. (a,c,e) Mean (± SEM) traces for rewarded
REMI choices in the 10 (a), 3 (c), and 1 (e) μg/kg conditions. (b,d,f) Mean (± SEM)
traces for reward-omitted REMI choices in the 10 (a), 3 (c), and 1 (e) μg/kg conditions.
All data were smoothed with 0.25 s moving window prior to averaging.
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Figure 4.8. Example O2 traces for food. Average O2 traces for Option B (food)
collapsing over relative reward rates and rats. (a,c,e) Mean (± SEM) traces for rewarded
food choices in the 10 (a), 3 (c), and 1 (e) μg/kg conditions. (b,d,f) Mean (± SEM) traces
for reward omitted food choices in the 10 (a), 3 (c), and 1 (e) μg/kg conditions. All data
were smoothed with 0.25 s moving window prior to averaging.
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Figure 4.9. Effects of relative reward rates on NAc O2. Mean (± SEM) O2 percent
amplitude changes for (a) peaks during the cue interval, (b) peaks during the reward
interval, and (c) troughs during the reward interval collapsing over all other conditions.
Note: x-axes are logarithmic for visualization.
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Figure 4.10. Cue interval peak O2 effects. (a) Mean (± SEM) O2 percent amplitude
changes for REMI and food as a function of dose. (b) Mean (± SEM) O2 percent
amplitude changes as a function choice outcome. (c) Mean (± SEM) O2 peak widths for
REMI-Wins, REMI-Losses, Food-Wins, and Food-Losses as a function of dose.
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Figure 4.11. Reward interval Peak O2 effects. (a) Mean (± SEM) O2 percent amplitude
changes for REMI-Wins, REMI-Losses, Food-Wins, and Food-Losses as a function of
dose. (b) Mean (± SEM) O2 peak widths for REMI-Wins, REMI-Losses, Food-Wins, and
Food-Losses as a function of dose.
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Figure 4.12. Reward interval trough O2 effects. (a) Mean (± SEM) O2 percent amplitude
change for REMI and food as a function of dose. (b) Mean (± SEM) O2 percent
amplitude change for wins and losses as a function of dose. (c) Mean (± SEM) O2 trough
widths as a function of REMI-Wins, REMI-Losses, Food-Wins, and Food-Losses as a
function of dose.
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Figure 4.13. Peak O2 correlation with modeled reward magnitudes. Correlation between
REMI’s behaviorally derived reward magnitude using the exchange parameter from
Equation 16 and the REMI to food ratio of peak O2 percent amplitude changes during the
reward interval.
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Figure 4.15. Peak O2 correlation with modeled reward prediction errors. Correlation
between the Scaled Quad-Learning reward prediction errors and the percent amplitude
peak O2 change during the reward interval for win trials.
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2.04 mm
Figure 4.14. Anatomical distribution of electrode placements. Circles represent the
placement of the tip of the O2 -sensitive microelectrode arrays in the NAc (n = 6). 2.04
mm indicates the anterior position relative to bregma.
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CHAPTER 5:
GENERAL DISCUSSION
The present set of experiments has benefitted our understanding of decision
making in several ways. First, across all three experiments, concatenated generalized
matching models (Baum, 1974; Rachlin, 1971) provided good descriptions of molar data
using only one sensitivity parameter for the dimensions of relative reward rates and
magnitudes. That the matching models were able capture rats’ choices for both the
isomorphic and allomorphic procedures substantiates the model’s predictions that choices
between alternatives are determined by the relative scaling of independent dimensions
(Kyonka, 2008; McDowell, 2013). As such, the present experiments suggest that the use
of either single schedules of reinforcement or unidimensional spaces of reward value,
such as unit price, are not a complete description of choice preferences. Single schedules
of reward value fail to incorporate the influence of competing commodities on reward
value, while proposed unidimensional spaces do not incorporate psychophysical
differences in how dimensions are scaled. Not accounting for the scaling of different
reward dimensions (e.g., cost, probability, magnitude, etc.) is also a theoretically
plausible reason why studies manipulating both the cost and magnitude of rewards show
violations of demand theory at equivalent unit prices (e.g., Madden et al., 2000; Smith et
al., 2016).
Another important finding across the current experiments was the replication of
reward-associated cues biasing choice for Option A in the Signaled groups for both
isomorphic food versus food and allomorphic drug versus food decision-making
conditions. The use of reward-associated cues in the Signaled groups from Experiments 1
and 2 stems research done primarily with pigeons (McDevitt et al., 2016; Zentall, 2016)
that has shown that cues can produce an incredible degree of insensitivity to the relative
reward rates between commodities. Stated differently, the reward-associated cues created
very strong biases where pigeons would repeatedly make suboptimal choices to the
detriment of losing out on as much as two and a half times the food had they chosen a
noncued alternative (Stagner & Zentall, 2010). Although well established in pigeons, the
translation of a suboptimal choice effect to rats was a debatable effect (Chow, Smith,
Wilson, Zentall, & Beckmann, 2017; Cunningham & Shahan, 2019; Smith et al., 2018;
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Trujano & Orduna, 2015). The current experiments add evidence suggesting that rats’
choices are indeed influenced by reward-associated cues and are also the first to show
that choices for drug commodities can be influenced via the same mechanisms as choices
for food rewards.
Although specifying the mechanism for why the reward-associated cues bias
choice is beyond the current scope of this thesis, Experiments 1 and 2 did show that the
mechanism is independent of an altered sensitivity to reward magnitude (i.e., SM).
Additionally, use of the 2-D Exchange Matching model (Equation 16) presented a novel
way to quantify the effects of biased choice in terms of a commodity’s relative
substitutability (Green & Freed, 1993; Rachlin et al., 1976). Substitutability refers to how
interchangeable two commodities are for each other. As the availability or cost of one
commodity (Commodity A) changes, switching preference to another commodity (e.g.,
Commodity B) reflects that this latter commodity (Commodity B) acts as an economic
substitute for the former (Commodity A). In the present experiments, decreases in the
relative reward rates and magnitudes for Option A resulted in relative increased
preferences for Option B across all experiments. As such, food was substituting for itself
and serving as an economic substitute for REMI drug reward (Anderson, Velkey, &
Woolverton, 2002; Beckmann et al., 2019; Koffarnus & Woods, 2008; Maguire, Gerak,
& France, 2013; Negus, 2006; Schwartz et al., 2017). The use of reward-associated cues
in the Signaled group also decreased the relative substitutability of Option B for Option
A. That is, an unsignaled food pellet did not substitute as well for a signaled food pellet
or REMI infusion relative to an unsignaled food pellet’s ability to substitute for an
unsignaled food pellet or REMI infusion. Overall, the results across experiments suggest
that reward-associated cues change the decision-making context in a qualitative way from
procedures lacking such cues.
Choice data were also analyzed at the molecular level using RL models (Sutton &
Barto, 1998), which make different assumptions from matching models. RL models
traditionally assume that each commodity is assigned value independent of others and is
updated according to a violation between expected and obtained reward (i.e., the RPE). In
all cases, formulations of RL models were successfully able to parameterize rats’
decision making, including decisions for drug reward; these results suggest that rats may
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choose alternatives through value-based decisions at a local, trial-by-trial level and
corroborate previous uses of RL models with rodents (Groman et al., 2017; Marshall &
Kirkpatrick, 2017). However, model-comparison results suggested that the assumption of
independent value updating was not substantiated. Changing the reward magnitude terms
into group-dependent ratios of scaled, relative reward value improved model fits to a
substantial degree. Further model comparisons also revealed that the addition of
parameters to allow for differential scaling of wins and losses was substantiated. That
wins and losses were differentially scaled corroborates a large body of research showing
the contextual-dependency of an individual’s decisions (Glimcher et al., 2013; Kahneman
& Tversky, 1979; Marshall & Kirkpatrick, 2017) and provides evidence that future
models may need to incorporate different weighting for wins versus losses. Together, the
results suggest that value updating is a relative, rather than independent, process and
highlights how the testing of model assumptions can aid understanding of decisionmaking processes.
Finally, as shown in Experiment 3, recordings of NAc O2 activity were generally
commensurate with the possibility of a common physiological utility signal in the brain
(Levy & Glimcher, 2012). NAc O2 responded primarily as peaks to outcome-associated
cues for both food and REMI, similar to previous research (e.g., Fiorillo et al., 2003;
O'Doherty, Buchanan, Seymour, & Dolan, 2006). However, the present study is believed
the first to use REMI as a reward commodity within a decision-making task while
concurrently recording from the NAc. Experiment 3 therefore expands previous literature
showing similar encoding of qualitatively different rewards (Levy & Glimcher, 2012) to
also include opioid μ receptor agonist rewards. Additionally, changes in the magnitude of
the peaks as a function of dose for food and REMI cues were of a manner suggestive of
NAc O2 scaling with the relative reward magnitude of food and REMI. However,
definitive conclusions regarding reward-signal scaling were complicated by potential
compensatory effects of cues for REMI infusions at the 10 μg/kg dose, warranting further
research.
NAc O2 activity also generally responded as peaks for both food and REMI
reward delivery, but only peaks to REMI-Wins dose-dependently scaled with reward
magnitude manipulations. That O2 changes for food during the reward interval did not
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vary as a function of dose may suggest that O2 changes to reward delivery reflect scaling
of reward magnitude but not in relative terms. Indeed, striatal-activity scaling with the
reward magnitude of a commodity on win trials is well established (Fiallos et al., 2017;
Levy & Glimcher, 2012), but methodological and/or analytical limitations often preclude
determination of whether regional activity scaling of reward magnitude is relative. Future
research is needed to confirm whether value in the NAc scales in relative or independent
manner. Finally, peak O2 during the reward interval significantly correlated with RLmodel-derived RPEs for both food and REMI, consistent with previous research
(Garrison et al., 2013). This result further corroborates the possibility that different
commodity types update value according to an RPE-like rule and may guide future
decisions.
Overall, the three experiments showed a relatively high degree of consistency in
the behavioral results and conclusions. The present experiments employed a dynamic,
probabilistic decision-making task previously used in monkeys and humans (Lau &
Glimcher, 2005; Rutledge et al., 2009) and showed evidence of rats making value-based
decisions by tracking the option with greater relative reward rates. Rats’ preferences were
also sensitive to increases in relative reward-magnitude changes, and NAc O2 activity
showed apparent sensitivity to both food- and REMI-related events that scaled with
increases in REMI dose. Together, the experiments suggest isomorphic food versus food
and allomorphic drug versus food choices were similarly mediated by the same valuebased decision-making mechanisms. The results corroborate a large literature on
economic choice theory (Davison & McCarthy, 1988; Glimcher, 2011) but also conflict
with many theoretical conceptualizations of SUDs, as described next.
Applications to Substance Use Disorders
The discussion of SUDs in the preclinical literature has been largely centered
around the disease model of addiction (e.g., Heather, 2017; Volkow et al., 2016). As a
broad description, drug use leads to biological changes (often in mesocorticolimbic nuclei
such as the NAc) that, for a variety of reasons, change the propensity of an individual to
make subsequent drug choices. Taken to an extreme, several theories of addiction posit
that the predicated biological changes produce insensitivities to consequences (i.e., habit;
Hogarth, 2018; Vandaele & Janak, 2018) or even a compulsion to continue to choose the
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drug (e.g., Robinson & Berridge, 2008; Vandaele, Cantin, Serre, Vouillac-Mendoza, &
Ahmed, 2016; Wise & Koob, 2014).
The allostatic theory of addiction predicts that drug choices are initially driven by
the positive reinforcement effects that drugs produce. After repeated use, the hedonic set
point of an individual changes through tolerance mechanisms requiring increased drug
use to both maintain positive rewarding effects of the drug and avoid withdrawal effects.
Indeed, drugs can produce rewarding effects that lead to drug choices (see Experiments 2
and 3), continued drug use can lead to biological tolerance (e.g., Grecksch et al., 2006;
Hooman Khademi, Farin Kamangar, Paul Brennan, & Reza Malekzadeh, 2016), and
being in a withdrawal state can increase the propensity to choose drug (Negus & Rice,
2009). Thus, each of the component of the allostatic theory has evidence substantiating
its claim.
However, a growing literature suggests much of the evidence for theories of
addiction can be accounted for by more general value-based mechanisms. For instance,
rats acutely deprived of food show increased motivation for food reward and hoarding
(Morgan et al., 1943), food deprivation can produce physiological brain alterations
(Blumenthal & Gold, 2010), and many humans report having experienced subjective
“cravings” for different foods (Mercer & Holder, 1997). Given the evidence of the effects
of food deprivation, it seems difficult to argue that the aforementioned components of the
allostatic theory of addiction are unique to drug rewards. Furthermore, the changes in the
brain on which many theories of addiction are predicated are correlational results
(Heyman, 2013a) that do not establish a causal link between drug-induced brain changes
and addiction-like behavior. Consider also that experiments using recordings of brainregion activity during decisions for food and drug (i.e., Experiment 3) increasingly show
qualitatively similar functional forms of activity between the rewards (e.g., Cameron et
al., 2014; Guillem et al., 2018; Levy & Glimcher, 2012). That changes in region activity
are of a similar form between drug and nondrug reward is in line with the idea of a
common physiological utility scale and further suggests that drug rewards may produce
preferences through value-based mechanisms similar to other rewards. Indeed, the
evidence from the current set of experiments supports the view that drug value was
modulated in a qualitatively similar way as nondrug value.
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Whereas compulsion often focuses on the positive and negative reinforcing nature
of drugs of abuse, habitual behavior often includes a learning component where behavior
is initially flexible and goal-directed but, with continued drug use, becomes an inflexible
and automatic response to reward- or drug-associated stimuli (Everitt & Robbins, 2005;
Hogarth, 2018; Robinson & Berridge, 2008; Vandaele & Janak, 2018). Prominent
examples of habitual control come from studies showing that prolonged drug use will
result in drug-seeking behavior despite concurrent foot shocks or presentations of shockassociated stimuli (Deroche-Gamonet, Belin, & Piazza, 2004; Vanderschuren & Everitt,
2004) or that drug rewards are not devalued by pairing with illness as food rewards are
(Dickinson, Wood, & Smith, 2002). However, similar to dysregulated drug use in the
escalation model (Beckmann et al., 2012), the formation of drug-associated habits also
appears to be dependent on the decision-making context, as choice procedures have
shown that drug choices remain goal-directed even after chronic use (Halbout, Liu, &
Ostlund, 2016; Negus, 2005; Pelloux, Murray, & Everitt, 2015).
Experiments 1 and 2 also employed differential use of reward-associated cues
between options in the Signaled and Unsignaled groups that could have produced
inflexible habit behavior. To be in line with habit theory, rats in the Signaled group
during the allomorphic choice procedure should have shown drug preferences that were
insensitive to changes relative reward rates and relative doses. However, the rewardassociated cues for food in Experiment 1 and drug in Experiment 2 produced the same
effect of biasing choice towards the cue-paired option. Additionally, drug choices even at
the 10 μg/kg condition showed significant sensitivity to changes in the relative reward
rates between choice options. Suboptimal choice research alluded to previously has also
shown that cues associated with food can produce robust changes in choice behavior that
violate standard economic models of maximizing expected reward value (Zentall, 2016).
However, in all reports of suboptimal choice to date, interpreting the cue-effects has been
through a value-based manner, and removal of the cue from the decision-making context
resulted in a return of individuals making choices in line with economic choice theories
(Smith et al., 2017a). Thus, conditioned stimuli can certainly affect behavior, but the
reward-associated cues in the present experiments biased choice for food and drug in a
qualitatively similar way that suggests a more general value-based mechanism.
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The idea of habitual or compulsive drug use is also challenged in human research
at the laboratory and population levels. For example, substance-using populations in
laboratory decision-making procedures have been shown to make decisions sensitive to
the relative reward magnitude, price, and delay of both nondrug (Moeller & Stoops,
2015) and drug commodities (Griffiths, Rush, & Puhala, 1996; Jones & Comer, 2013;
Moeller & Stoops, 2015). Results from the laboratory decision-making experiments are
also corroborated by contingency management programs (Davis et al., 2016; Holtyn et
al., 2014; Lussier, Heil, Mongeon, Badger, & Higgins, 2006) that typically offer gift or
monetary vouchers contingent upon drug abstinence for a predetermined period of time.
Contingency management programs are largely effective in curbing drug use, with better
outcomes for programs that persist for longer or offered abstinence-contingent rewards of
a larger reward magnitude. Furthermore, a number of substance users appear to remit on
their own without treatment or “mature out” of dependence (Heyman, 2013a;
Klingemann, Sobell, & Sobell, 2010). Indeed, perhaps the most prominent example of
individuals remitting on their own for opioid use disorder comes from veterans returning
from the Vietnam War (Robins, 1993). Heroin use during the Vietnam War was
described as an epidemic with prevalence estimates for regular use between 20-30% of
surveyed individuals. However, upon returning home, more than two thirds of the
previously heroin-using veterans had no heroin use 8-10 months later. If addiction is
caused by drug-induced brain changes leading to compulsive habits, it is difficult to
reconcile the evidence of individuals abstaining on their own or that abstinence can be
“bought” through contingency management programs (Heather, 2017; Heyman, 2013a).
The aforementioned lines of evidence conflicting with compulsive habit theories
suggest a major factor when considering drug-choice propensity: the availability of
alternative substitutes (Ahmed, 2005; Beckmann et al., 2019). When the only option
available to an individual is to take drug as in single schedules, behavioral symptoms
congruent with compulsive habits emerge. When another alternative commodity that can
compete with drug reward is available, compulsive behavior is often absent and drug
preferences depend upon the relative position of each reward along many dimensions of
reward value (i.e., concatenated matching).
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The importance of choice preferences being relative, while seemingly simple,
cannot be understated. As just described, many papers have suggested that drug reward
results in compulsive and habitual behavior due to drugs’ inherently superior reward
value. The opposite end of the spectrum also exists. Some research groups have
suggested that drug rewards are in fact inherently inferior (Ahmed, Lenoir, & Guillem,
2013; Cantin et al., 2010; Lenoir et al., 2007; Venniro et al., 2018) due to being unable to
show preference reversals as a function of increases in the drug dose offered during
choice procedures. However, neither drug nor nondrug rewards are inherently better than
the other. Preferences depend on the decision-making context, and the dose of the drug
(i.e., reward magnitude) is only one of many operable dimensions that can modulate
reward value. For instance, consider the allomorphic choice results of Experiment 2
(Figure 3.1b-c). One would have a particularly hard time trying to describe whether
REMI or food was the more rewarding commodity. If the REMI dose offered is 10 μg/kg,
REMI is largely preferred, but if the REMI dose is 1 μg/kg, food is largely preferred. In a
similar way, a 3-μg/kg infusion of REMI is weakly preferred to food when it is paired
with a reward-associated stimulus with favorable reward rates but not when the reward
rates favor food and never when the infusion is unsignaled. Although failure to produce
dose-dependent drug preferences (as described above) was surprising, concluding a
commodity-superiority hierarchy off the basis of so few dimensional manipulations may
be inappropriate. Had Experiment 2 only tested the Unsignaled group using 1 and 3
μg/kg infusions, a conclusion of drugs being inferior rewards might also have been
satisfied. Instead, future research should test many points along many reward dimensions
(e.g., delay, effort, probability, magnitude).
Changing the Conversation About SUDs
The conceptualization of SUDs in the present thesis has largely been centered on
conflicting hypotheses that SUDs are driven by a manifestation of biologically-mediated
compulsion or by a disorder of choice. Drug choice in the present experiments showed no
evidence of compulsion, and the present results corroborate a larger body of work
advocating that SUDs may be well described as a disorder of choice. However, biological
mechanisms mediating SUDs are still critical determinants of such behaviors. For
example, physical dependence and withdrawal are important risk factors that can change
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an individual’s propensity to make drug choices (Negus & Rice, 2009; Williams et al.,
2001). Additionally, pharmacotherapies, such as agonist replacement therapies, have
shown efficacy in reducing drug choices (Kampman & Jarvis, 2015; Rush & Stoops,
2012). Thus, SUDs should continue to be discussed as an interaction between decisionmaking mechanisms and biological mechanisms.
Although biological variables are important and can influence drug choices,
compulsive drug choice does not seem a useful description that will facilitate future
research or treatment approaches (Heather, 2017; Heyman, 2013a; Hogarth, 2018). For
instance, the meaning of “compulsive choice” is somewhat vacuous, as it is not used
consistently within the field (Heather, 2017) and often appears to act as a synonym for
“strong preference” (Heyman, 2003). Some may argue that the debate of word choice is
merely semantics, but the idea of a strong preference has a place within choice and
decision-making theories whereas compulsions currently do not. Indeed, reframing words
like compulsion or craving into a state-dependent bias for a commodity has found success
in studies attempting to quantify the effects of “craving” on choice preferences (Konova,
Louie, & Glimcher, 2018). Using different terms does not change the complexity of
SUDs, but it may facilitate future research by speaking on more common grounds that
could be supported by mathematical choice models.
A final point to consider is what the characterization of SUDs as a disorder of
choice might mean at a policy level. For instance, some may disagree with the idea of
conceptualizing SUDs as a disorder of choice, not for scientific reasons, but because
calling drug use a choice may implicate a social stigma such that individuals would not
be deserving of help or treatment (Heather, 2017). Indeed, social stigmatization
represents a pertinent issue for drug users (Lloyd, 2013), but it is also one that is already
present in our society. Furthermore, although a disease model characterization of SUDs
may exonerate the individual of blame to some degree, it may also remove the locus of
control from the individual and generate a feeling of powerlessness to change (Heather,
2017).
A choice model of SUDs also does not have to mean that drug choices are failures
of self-control or volitional will power. Some posited choice theories are able to describe
how an individual may behave as if they are compulsively choosing drug but are actually
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maximizing utility (Heyman, 2013b; Rachlin, 1997). As previously described, these
choice theories dissociate between maximizing local utility (i.e., at the present moment)
versus global utility (i.e., longer term utility). If a drug of abuse is chosen, then one
assumes that the drug produced greater local utility relative to other available substitutes
at the time of choice. As such, an individual maximizing local utility will myopically
continue to choose drug reward until a better alternative becomes available. However,
with continued use, the repeated drug choices decrease its own subjective utility (due to
tolerance) but may also decrease the utility of other potential substitutes. For instance,
drug choices can preclude the availability of future substitutes through social isolation,
job loss, incarceration, and declining health. Additionally, the benefits of choosing drug
reward are immediate, while both drug-associated costs and many alternative rewards
have delayed and uncertain outcomes that results in a decreased impact on behavior.
Thus, although staying healthy, spending time with friends and family, or maintaining a
job might produce overall greater utility, at the time of choice, drug reward produces
greater local utility. As such, it is possible for an individual to choose as if they are
compulsively seeking drug but may instead be maximizing utility without invoking ideas
about compulsion or willpower. Alternatively, a compulsive individual should not show
value-based decision making as in the present experiments and may suggest a valuebased conceptualization of SUDs offers a viable alternative.
Another main point from the above example is that the availability of economic
substitutes for drug reward is one possible mechanism to decrease drug choice and is
consistent with the results of the current experiments. Availability of substitutes may also
be a moderating factor of drug use at a systemic level within society. For example,
preclinical models that provide rats with an enriching environment full of toys,
conspecifics, and access to running wheels can reduce drug choices (Alexander, Coambs,
& Hadaway, 1978; Bardo, Klebaur, Valone, & Deaton, 2001; Hofford, Chow, Beckmann,
& Bardo, 2017), while rats in impoverished conditions lacking the available substitutes
choose drug more often. Although not a perfect metaphor, the effects of enrichment
certainly seem to parallel the findings that individuals of lower socioeconomic status are
more prone to drug use (Galea & Vlahov, 2002; Williams & Latkin, 2007) and may
reflect a lack of available alternatives to drug rewards. Clearly, decisions on how to
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conceptualize SUDs are complicated, but avoiding a choice model for fear of a societally
placed stigma may also preclude discussion leading to potential treatments.
Conclusions
The purpose of the present experiments was to assess whether predictions of
economic choice theory were upheld in an allomorphic drug versus food choice
procedure. Namely, the predictions were that choices for drug reward would be sensitive
to changes in relative reward rates and magnitudes. In Experiment 1, the isomorphic food
versus food procedure was shown to provide a valid preclinical model of probabilistic
decision making in rats, in which choices were sensitive to the relative reward rates and
magnitudes of concurrently available options. For allomorphic drug versus food decision
making in Experiment 2, the results did not change. Rats’ choices between the opioid μ
receptor agonist remifentanil and food still showed sensitivity to relative reward rates and
magnitudes, suggesting that rats chose as if through value-based decision-making
processes. Finally, Experiment 3 was generally commensurate the possibility of a
common physiological reward signal between REMI and food within the NAc. Namely,
both reward types showed similar peaks to reward-related events and Nac O2 dosedependently scaled with REMI infusions. The results have potentially broad implications
for current conceptualizations of SUDs, including a potential need to change the way
SUDs are discussed and modeled in preclinical experiments. Overall, the present set of
experiments provides additional evidence that a choice model of SUDs may be a viable
alternative to the disease model and could provide insight into novel treatments based on
economic principles of reward value.
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